<SEC-DOCUMENT>0001104659-24-125776.txt : 20241205
<SEC-HEADER>0001104659-24-125776.hdr.sgml : 20241205
<ACCEPTANCE-DATETIME>20241205081521
ACCESSION NUMBER:		0001104659-24-125776
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20241204
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20241205
DATE AS OF CHANGE:		20241205

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AUDIOEYE INC
		CENTRAL INDEX KEY:			0001362190
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-PREPACKAGED SOFTWARE [7372]
		ORGANIZATION NAME:           	06 Technology
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38640
		FILM NUMBER:		241527916

	BUSINESS ADDRESS:	
		STREET 1:		5210 E. WILLIAMS CIRCLE
		STREET 2:		SUITE 750
		CITY:			TUCSON
		STATE:			AZ
		ZIP:			85711
		BUSINESS PHONE:		866-331-5324

	MAIL ADDRESS:	
		STREET 1:		5210 E. WILLIAMS CIRCLE
		STREET 2:		SUITE 750
		CITY:			TUCSON
		STATE:			AZ
		ZIP:			85711
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2430240d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:aeye="http://audioeyeinc.com/20241204">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_032_aeye_audioeyeinc.com_20241204 -->
<!-- Field: Set; Name: xdx; ID: xdx_040_20241204_20241204 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_057_edei%2D%2DEntityCentralIndexKey_0001362190 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2024-12-04" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2024-12-04" id="Fact000004" name="dei:EntityCentralIndexKey">0001362190</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="aeye-20241204.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2024-12-04">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001362190</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-12-04</xbrli:startDate>
        <xbrli:endDate>2024-12-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-transform: uppercase"><b>Washington</b></span><b>,
DC 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_904_edei--DocumentType_c20241204__20241204_zjxGGRVFgBma"><ix:nonNumeric contextRef="AsOf2024-12-04" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section 13 or 15(d) of the</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event
reported): <b><span id="xdx_902_edei--DocumentPeriodEndDate_c20241204__20241204_zvEINUrjG9D5"><ix:nonNumeric contextRef="AsOf2024-12-04" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">December 4, 2024</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_906_edei--EntityRegistrantName_c20241204__20241204_zyX5LCB6Vruf"><ix:nonNumeric contextRef="AsOf2024-12-04" id="Fact000011" name="dei:EntityRegistrantName">AUDIOEYE, INC.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in
charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 33%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_906_edei--EntityIncorporationStateCountryCode_c20241204__20241204_zygJTrXD6WJd"><ix:nonNumeric contextRef="AsOf2024-12-04" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="width: 34%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90D_edei--EntityFileNumber_c20241204__20241204_zOGGRfFEiOZ1"><ix:nonNumeric contextRef="AsOf2024-12-04" id="Fact000013" name="dei:EntityFileNumber">001-38640</ix:nonNumeric></span></b></span></td>
    <td style="width: 33%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90C_edei--EntityTaxIdentificationNumber_c20241204__20241204_zDmoVA6PsQsi"><ix:nonNumeric contextRef="AsOf2024-12-04" id="Fact000014" name="dei:EntityTaxIdentificationNumber">20-2939845</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-size: 10pt">State of Other&#8239;Jurisdiction of <br/>
Incorporation</span></td>
    <td style="text-align: center"><span style="font-size: 10pt">Commission File Number</span></td>
    <td style="text-align: center"><span style="font-size: 10pt">IRS Employer Identification No.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_904_edei--EntityAddressAddressLine1_c20241204__20241204_zXq0P5LFX1q7"><ix:nonNumeric contextRef="AsOf2024-12-04" id="Fact000015" name="dei:EntityAddressAddressLine1">5210 E. Williams Circle</ix:nonNumeric></span>, <span id="xdx_905_edei--EntityAddressAddressLine2_c20241204__20241204_zMyQRHwPINSg"><ix:nonNumeric contextRef="AsOf2024-12-04" id="Fact000016" name="dei:EntityAddressAddressLine2">Suite 750</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90D_edei--EntityAddressCityOrTown_c20241204__20241204_zTVeoAoFZzud"><ix:nonNumeric contextRef="AsOf2024-12-04" id="Fact000017" name="dei:EntityAddressCityOrTown">Tucson</ix:nonNumeric></span>, <span id="xdx_902_edei--EntityAddressStateOrProvince_c20241204__20241204_zjY4JaKRZSik"><ix:nonNumeric contextRef="AsOf2024-12-04" format="ixt-sec:stateprovnameen" id="Fact000018" name="dei:EntityAddressStateOrProvince">Arizona</ix:nonNumeric></span> <span id="xdx_901_edei--EntityAddressPostalZipCode_c20241204__20241204_zrONXLJHfLba"><ix:nonNumeric contextRef="AsOf2024-12-04" id="Fact000019" name="dei:EntityAddressPostalZipCode">85711</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of principal executive offices / Zip Code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>(<span id="xdx_90A_edei--CityAreaCode_c20241204__20241204_zFkKYf0vIxlk"><ix:nonNumeric contextRef="AsOf2024-12-04" id="Fact000020" name="dei:CityAreaCode">866</ix:nonNumeric></span>) <span id="xdx_902_edei--LocalPhoneNumber_c20241204__20241204_zuOEwvXagxYb"><ix:nonNumeric contextRef="AsOf2024-12-04" id="Fact000021" name="dei:LocalPhoneNumber">331-5324</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">(Registrant&#8217;s
telephone number, including area code)</p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Check the appropriate box below if the Form
8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font: 10pt Wingdings"><span id="xdx_909_edei--WrittenCommunications_c20241204__20241204_zvWQnZvyQjtl"><ix:nonNumeric contextRef="AsOf2024-12-04" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span></td>
    <td><span style="font-size: 10pt">Written communications pursuant to Rule 425 under the Securities Act.</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font: 10pt Wingdings"><span id="xdx_902_edei--SolicitingMaterial_c20241204__20241204_z3KLlPexh4y6"><ix:nonNumeric contextRef="AsOf2024-12-04" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span></td>
    <td><span style="font-size: 10pt">Soliciting material pursuant to Rule 14a-12 under the Exchange Act.</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font: 10pt Wingdings"><span id="xdx_90B_edei--PreCommencementTenderOffer_c20241204__20241204_zpkTFLREOaQe"><ix:nonNumeric contextRef="AsOf2024-12-04" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span></td>
    <td><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font: 10pt Wingdings"><span id="xdx_904_edei--PreCommencementIssuerTenderOffer_c20241204__20241204_zv3Xed6c7T43"><ix:nonNumeric contextRef="AsOf2024-12-04" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span></td>
    <td><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.7in; text-indent: -0.7in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section 12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 45%; text-align: center"><span style="font-size: 10pt"><b>Title of each class</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 11%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Trading</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Symbol(s)</b></p></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 42%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Name of each exchange</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>on which registered</b></p></td></tr>
  <tr>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_900_edei--Security12bTitle_c20241204__20241204_zHuWpahsH89j"><ix:nonNumeric contextRef="AsOf2024-12-04" id="Fact000026" name="dei:Security12bTitle">Common Stock, par value $0.00001 per share</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_903_edei--TradingSymbol_c20241204__20241204_zYzdlZFigNak"><ix:nonNumeric contextRef="AsOf2024-12-04" id="Fact000027" name="dei:TradingSymbol">AEYE</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt"><b>The <span id="xdx_90A_edei--SecurityExchangeName_c20241204__20241204_zvec7dX8laqg"><ix:nonNumeric contextRef="AsOf2024-12-04" format="ixt-sec:exchnameen" id="Fact000028" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric> </span>Capital Market</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Emerging growth company <span style="font-family: Wingdings"><span id="xdx_908_edei--EntityEmergingGrowthCompany_c20241204__20241204_zet4YVz8wPm3"><ix:nonNumeric contextRef="AsOf2024-12-04" format="ixt:booleanfalse" id="Fact000029" name="dei:EntityEmergingGrowthCompany">&#168;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family: Wingdings">&#168;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 12pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 12%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 1.01</b></span></td>
    <td style="width: 88%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Entry into a Material Definitive Agreement.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">On December&#160;4, 2024,
AudioEye,&#160;Inc. (the &#8220;Company&#8221;) entered into an underwriting agreement (the &#8220;Underwriting Agreement&#8221;) with
Needham&#160;&amp; Company, LLC, as the representative of the underwriters (the &#8220;Representative&#8221;), and entities affiliated
with David Moradi, Dr.&#160;Carr Bettis and Jamil Tahir (collectively, the &#8220;Selling Stockholders&#8221;) relating to the public
secondary offering (the &#8220;Offering&#8221;) of the Company&#8217;s common stock, par value $0.00001&#160;per share (&#8220;Common
Stock&#8221;). Pursuant to the Underwriting Agreement, the Selling Stockholders agreed to sell an aggregate of 1,250,000 shares of Common
Stock to the underwriters at a public offering price of $24.00 per share. Under the terms of the Underwriting Agreement, the Selling Stockholders
granted the underwriters an option, exercisbable for 30 days, to purchase up to an additional 187,500 shares of Common Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Company will not
sell any shares of its Common Stock in the Offering and will not receive any proceeds from the sale of shares of Common Stock by the Selling
Stockholders in the Offering. The Offering is expected to close on December&#160;6, 2024, subject to the satisfaction of customary closing
conditions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><br/>
The Offering is being made pursuant to the Company&#8217;s registration statement on Form&#160;S-3 (File No.&#160;333-276937), which
was filed with the Securities and Exchange Commission (the &#8220;Commission&#8221;) on February&#160;7, 2024 and declared effective
by the Commission on February&#160;13, 2024, and related prospectus supplement filed with the Commission on December&#160;5, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Underwriting Agreement
contains customary representations, warranties, and agreements by the Company and the Selling Stockholders; customary conditions to closing;
indemnification obligations of the Company, the Selling Stockholders and the underwriters, including for liabilities under the Securities
Act of 1933, as amended; other obligations of the parties; and termination provisions. Pursuant to the Underwriting Agreement, the Company
agreed, subject to certain exceptions, not to offer, issue, or sell any shares of Common Stock or securities convertible into or exercisable
or exchangeable for shares of Common Stock for a period of 90 days following the Offering without the prior written consent of the underwriters.
In addition, pursuant to the terms of the Underwriting Agreement, each of the Company&#8217;s directors, executive officers, and certain
stockholders have entered into lock-up agreements that generally prohibit, subject to certain limited exemptions, the sale, transfer or
other disposition of securities of the Company for a period of 90 days without the prior written consent of the Representative.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The foregoing is only
a brief description of the terms of the Underwriting Agreement, does not purport to be a complete description of the rights and obligations
of the parties thereunder, and is qualified in its entirety by reference to the Underwriting Agreement that is filed as Exhibit&#160;1.1
to this Current Report on Form&#160;8-K and incorporated by reference herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 12%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 8.01</b></span></td>
    <td style="width: 88%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other Events</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">On December&#160;4, 2024
and December&#160;5, 2024 the Company issued press releases announcing the launch of the Offering (the &#8220;Launch Press Release) and
the pricing of the Offering (the &#8220;Pricing Press Release&#8221;), respectively. Copies of the Launch Press Release and the Pricing
Press Release are attached as Exhibits 99.1 and 99.2 to this report, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 12%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 9.01</b></span></td>
    <td style="width: 88%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financial Statements and Exhibits.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(d)&#160;Exhibits:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 12%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit&#160;Number</span></td>
    <td style="width: 88%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Description</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><a href="tm2430240d1_ex1-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</span></a></td>
    <td style="text-align: justify"><a href="tm2430240d1_ex1-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriting Agreement, dated as of December&#160;4, 2024, by and among the Company, Needham&#160;&amp; Company, LLC, as representative of the underwriters, and the Selling Stockholders listed therein.</span></a></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><a href="tm2430240d1_ex99-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></a></td>
    <td style="text-align: justify"><a href="tm2430240d1_ex99-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press release, dated December&#160;4, 2024</span></a></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><a href="tm2430240d1_ex99-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.2</span></a></td>
    <td style="text-align: justify"><a href="tm2430240d1_ex99-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press release, dated December&#160;5, 2024</span></a></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page&#160;Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December&#160;5, 2024</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AudioEye,&#160;Inc.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Registrant)</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 50%">&#160;</td>
    <td style="width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1pt solid; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;/s/ David Moradi</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: </span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">David Moradi</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjV0KwjAQhE/QOyx5lpoGi9BHi4pYpRQRX4NdJdhmyyb+9Eje0tgiLgvLMvPNCDERa1qZBhlOi6qAA7Zdoz1ChRdktGcMjnyzzSDcCq/GedbWD+8PzCkwGJg0VkoHYbA+jMM6AzmbJvOpmoFMM6mg3Inoq+dkL6ZG641uQNsaSqaODXrN/Zhw0C+y1PZD1RHZGbIZJLEc5TcomSjY00M/iW8OiiIX0WSYSKyZ7l1wLV8e7ZeEZYNtqHMj/d/oAwW2Sos= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>tm2430240d1_ex1-1.htm
<DESCRIPTION>EXHIBIT 1.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Exhibit
1.1&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>1,250,000
Shares</B></FONT>*</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AUDIOEYE,&nbsp;INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>UNDERWRITING AGREEMENT</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">December&nbsp;4, 2024</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-variant: small-caps">Needham&nbsp;&amp;
Company, LLC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As Representative of the several Underwriters</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#8239;&#8239;&#8239;&#8239;c/o
Needham&nbsp;&amp; Company, LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">250 Park Avenue</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">New York, New York 100177</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The stockholders of AudioEye,&nbsp;Inc.,
a Delaware corporation (the &ldquo;Company&rdquo;), named in Schedule II hereto (the &ldquo;Selling Stockholders&rdquo;) propose to sell
an aggregate of 1,250,000 shares (the &ldquo;Firm Shares&rdquo;) of the Company&rsquo;s common stock, $0.00001 par value per share (the
 &ldquo;Common Stock&rdquo;), in each case to you and to the several other Underwriters named in Schedule I hereto (collectively, the
 &ldquo;Underwriters&rdquo;), for whom you are acting as representative (the &ldquo;Representative&rdquo;). The Selling Stockholders have
also agreed to grant to you and the other Underwriters an option (the &ldquo;Option&rdquo;) to purchase up to an additional 187,500 shares
of Common Stock, on the terms and for the purposes set forth in Section&nbsp;1(b)&nbsp;(the &ldquo;Option Shares&rdquo;). The Firm Shares
and the Option Shares are referred to collectively herein as the &ldquo;Shares.&rdquo;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Company and, where applicable,
each of the Selling Stockholders confirm as follows their respective agreements with the Representative and the several other Underwriters.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><I>Agreement
to Sell and Purchase.</I></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">On
the basis of the representations, warranties and agreements of the Company and the Selling Stockholders herein contained and subject
to all the terms and conditions of this Underwriting Agreement (the &ldquo;Agreement&rdquo;), (i)&nbsp;each Selling Stockholder, severally
and not jointly, agrees to sell to the several Underwriters the respective number of Firm Shares set forth opposite that Selling Stockholder&rsquo;s
name on Schedule II hereto and (ii)&nbsp;each of the Underwriters, severally and not jointly, agrees to purchase from the Selling Stockholders
the respective number of Firm Shares set forth opposite that Underwriter&rsquo;s name in Schedule&nbsp;I hereto, at the purchase price
of $22.80 for each Share.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Subject
to all the terms and conditions of this Agreement, the Selling Stockholders grant the Option to the several Underwriters to purchase,
severally and not jointly, up to the maximum number of Option Shares set forth in Schedule II hereto at the same price per Share as the
Underwriters shall pay for the Firm Shares. The Option may be exercised in whole or in part at any time on or before the 30th day after
the date of this Agreement upon written or telegraphic notice (an &ldquo;Option Shares Notice&rdquo;) by the Representative to the Company
and such Selling Stockholders no later than 12:00&nbsp;noon, New York City time, at least one and no more than five business days before
the date specified for closing in the Option Shares Notice (an &ldquo;Option Closing Date&rdquo;), setting forth the aggregate number
of Option Shares to be purchased and the time and date for such purchase. On an Option Closing Date, each of such Selling Stockholders
will sell to the Underwriters the number of Option Shares determined by multiplying the number of Option Shares set forth in the applicable
Option Shares Notice by a fraction, the numerator of which is the maximum number of Option Shares set forth opposite the name of such
Selling Stockholder in Schedule II hereto and the denominator of which is the maximum number of Option Shares that all of the Selling
Stockholders are obligated to sell hereunder, as adjusted by the Representative in such manner as they deem advisable to avoid fractional
Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">* Plus an option to purchase up to an additional 187,500 shares to
cover over-allotments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><I>Delivery
and Payment. </I>Delivery of the Firm Shares shall be made to or as instructed by the Representative for the accounts of the several
Underwriters in a form reasonably acceptable to the Representative against payment by the Underwriters of the purchase price by wire
transfer payable in same-day funds to the Selling Stockholders at the office of Needham&nbsp;&amp; Company, LLC, 250 Park Avenue, New
York, New York 10177, at 10:00&nbsp;a.m., New York City time, on the business day (or, if the purchase price set forth in Section&nbsp;1(a)&nbsp;hereof
is determined after 4:30 p.m., New York City time, the second) after the date of this Agreement, or at such time on such other date,
not later than seven business days after the date of this Agreement, as may be agreed upon by the Company and the Representative (such
date is hereinafter referred to as the &ldquo;Closing Date&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To the extent the Option
is exercised, delivery of the Option Shares against payment by the Underwriters (in the manner specified above) will take place at the
offices specified above for the Closing Date at the time and date (which may be the Closing Date) specified in the applicable Option
Shares Notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Shares shall be in certificated
form, book-entry form, or held in brokerage accounts, and shall be registered in such names and in such denominations as the Representative
shall request at least one business day prior to the Closing Date or the applicable Option Closing Date, as the case may be, by written
notice to the Selling Stockholders. The Shares shall be delivered by or on behalf of the Selling Stockholders as instructed by the Representative
through the facilities of The Depository Trust Company (&ldquo;DTC&rdquo;) for any Shares in book-entry form, or though the respective
brokerage accounts for any Shares held in brokerage accounts. If the Representative so elects, delivery of the Shares may be made by
credit through full FAST transfer to the accounts at DTC designated by the Representative.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The cost of original issue
tax stamps and other transfer taxes, if any, in connection with the delivery of the Firm Shares and Option Shares by the Selling Stockholders
to the respective Underwriters, whether such Shares are held in certificated form, book-entry form or in brokerage accounts, shall be
borne by the Selling Stockholders. The Selling Stockholders will pay and save each Underwriter and any subsequent holder of the Shares
harmless from any and all liabilities with respect to or resulting from any failure or delay in paying federal and state stamp and other
transfer taxes, if any, which may be payable or determined to be payable in connection with the sale to such Underwriter of the Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For Shares held in brokerage
accounts, the Selling Stockholders shall ensure that such Shares are transferred to the accounts designated by the Representative at
least one business day prior to the Closing Date or the applicable Option Closing Date, as the case may be. The Selling Stockholders
shall provide the Representative with all necessary information and documentation to facilitate the transfer of such Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><I>Representations
and Warranties of the Company.</I>The Company represents, warrants and covenants to each Underwriter that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company meets the requirements for the use of Form&nbsp;S-3, a registration statement (Registration No.&nbsp;333-276937) on Form&nbsp;S-3
relating to the Shares, including a base prospectus relating to the Shares (the &ldquo;Base Prospectus&rdquo;) and such amendments thereto
as may have been required to the date of this Agreement, has been prepared by the Company under the provisions of the Securities Act
of 1933, as amended (the &ldquo;Act&rdquo;), and the rules&nbsp;and regulations (collectively referred to as the &ldquo;Rules&nbsp;and
Regulations&rdquo;) of the Securities and Exchange Commission (the &ldquo;Commission&rdquo;) thereunder, has been filed with the Commission,
and has been declared effective by the Commission, and the offering of the Shares complies with Rule&nbsp;415 under the Act. A final
prospectus supplement to the Base Prospectus relating to the Shares and the offering thereof will be filed promptly by the Company with
the Commission in accordance with Rule&nbsp;424(b)&nbsp;of the Rules&nbsp;and Regulations (such final prospectus supplement, as so filed,
the &ldquo;Prospectus Supplement&rdquo;). Such registration statement at any given time, including the amendments thereto to such time,
the exhibits and any schedules thereto at such time, the documents otherwise deemed to be a part thereof or included therein by the Rules&nbsp;and
Regulations (including Rule&nbsp;430B thereof), and any registration statement relating to the offering contemplated by this Agreement
and filed pursuant to Rule&nbsp;462(b)&nbsp;of the Rules&nbsp;and Regulations (&ldquo;Rule&nbsp;462(b)&rdquo;), is herein called the
 &ldquo;Registration Statement.&rdquo; The term &ldquo;preliminary prospectus&rdquo; means any preliminary prospectus (including any preliminary
prospectus supplement) relating to the Shares and the offering thereof as first filed with the Commission pursuant to Rule&nbsp;424(b)&nbsp;of
the Rules&nbsp;and Regulations (&ldquo;Rule&nbsp;424(b)&rdquo;). The term &ldquo;Prospectus&rdquo; means the Base Prospectus together
with the Prospectus Supplement, except that if such Base Prospectus is amended or supplemented on or prior to the date on which the Prospectus
Supplement was first filed pursuant to Rule&nbsp;424(b), the term &ldquo;Prospectus&rdquo; shall mean the Base Prospectus as so amended
or supplemented and as supplemented by the Prospectus Supplement. Any reference herein to the Registration Statement, the Base Prospectus,
a preliminary prospectus, the Prospectus Supplement, or the Prospectus shall be deemed to refer to and include the documents incorporated
by reference therein, and any reference herein to the terms &ldquo;amend,&rdquo; &ldquo;amendment&rdquo; or &ldquo;supplement&rdquo;
with respect to the Registration Statement, the Base Prospectus, a preliminary prospectus, the Prospectus Supplement, or the Prospectus
shall be deemed to refer to and include the filing of any document under the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange
Act&rdquo;), after the time the Registration Statement initially became effective (the &ldquo;Effective Date&rdquo;), the date of the
Base Prospectus, any preliminary prospectus, the Prospectus Supplement, or the Prospectus, as the case may be, and deemed to be incorporated
therein by reference. The term &ldquo;Issuer Free Writing Prospectus&rdquo; means any &ldquo;issuer free writing prospectus,&rdquo; as
defined in Rule&nbsp;433 of the Rules&nbsp;and Regulations (&ldquo;Rule&nbsp;433&rdquo;), relating to the Shares in the form filed or
required to be filed with the Commission or, if not required to be filed, in the form retained in the Company&rsquo;s records pursuant
to Rule&nbsp;433(g).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">No
order preventing or suspending the use of the Base Prospectus, any preliminary prospectus, the Prospectus Supplement, the Prospectus
or any Issuer Free Writing Prospectus has been issued by the Commission, and no stop order suspending the effectiveness of the Registration
Statement (including any related registration statement filed pursuant to Rule&nbsp;462(b)) or any post-effective amendment thereto has
been issued, and no proceeding for that purpose has been initiated or threatened by the Commission. On the Effective Date, on the date
the Base Prospectus, any preliminary prospectus, the Prospectus Supplement, or the Prospectus is first filed with the Commission pursuant
to Rule&nbsp;424(b)&nbsp;(if required), at all times during the period through and including the Closing Date and, if later, the applicable
Option Closing Date and when any post-effective amendment to the Registration Statement becomes effective or any amendment or supplement
to the Prospectus is filed with the Commission, the Registration Statement and the Prospectus (as amended or as supplemented if the Company
shall have filed with the Commission any amendment or supplement thereto), including the financial statements included or incorporated
by reference in the Prospectus, did and will comply with all applicable provisions of the Act, the Exchange Act, the rules&nbsp;and regulations
of the Commission under the Exchange Act (the &ldquo;Exchange Act Rules&nbsp;and Regulations&rdquo;), and the Rules&nbsp;and Regulations
and will contain all statements required to be stated therein in accordance with the Act, the Exchange Act, the Exchange Act Rules&nbsp;and
Regulations, and the Rules&nbsp;and Regulations. As of the applicable effective date as to each part of the Registration Statement, no
part of the Registration Statement, the Prospectus or any such amendment or supplement thereto did or will contain an untrue statement
of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein
not misleading. At the Effective Date, the date the Base Prospectus or any amendment or supplement to the Base Prospectus, including
any preliminary prospectus or the Prospectus Supplement, is filed with the Commission, the date of first use of any preliminary prospectus
or the Prospectus Supplement, and at the Closing Date and, if later, the applicable Option Closing Date, the Prospectus did not and will
not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in the
light of the circumstances under which they were made, not misleading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As of the Applicable Time,
neither (x)&nbsp;the Issuer General Use Free Writing Prospectus(es) (as defined below) issued at or prior to the Applicable Time (as
defined below), the Pricing Prospectus (as defined below) and the documents and information listed on Schedule III hereto, all considered
together (collectively, the &ldquo;General Disclosure Package&rdquo;), nor (y)&nbsp;any individual Issuer Limited Use Free Writing Prospectus,
when considered together with the General Disclosure Package, included any untrue statement of a material fact or omitted to state any
material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As used in this subsection
and elsewhere in this Agreement:</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;Applicable Time&rdquo;
means 6:45 p.m.&nbsp;(Eastern time) on December&nbsp;4, 2024 or such other time as agreed by the Company and Needham&nbsp;&amp; Company,
LLC.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;SEC Reports&rdquo;
shall mean the documents or portions thereof filed with the Commission on or prior to the Effective Date that are incorporated by reference
in the Registration Statement or the Prospectus and any documents or portions thereof filed with the Commission after the Effective Date
that are deemed to be incorporated by reference in the Registration Statement or the Prospectus.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;Issuer General Use
Free Writing Prospectus&rdquo; means any Issuer Free Writing Prospectus that is intended for general distribution to prospective investors,
as evidenced by its being specified in Schedule III hereto.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;Issuer Limited Use
Free Writing Prospectus&rdquo; means any Issuer Free Writing Prospectus that is not an Issuer General Use Free Writing Prospectus. The
term Issuer Limited Use Free Writing Prospectus also includes any &ldquo;<I>bona fide </I>electronic road show,&rdquo; as defined in
Rule&nbsp;433, that is made available without restriction pursuant to Rule&nbsp;433(d)(8)(ii), even though not required to be filed with
the Commission.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;Pricing Prospectus&rdquo;
means the Base Prospectus, as amended or supplemented immediately prior to the Applicable Time, including any document incorporated by
reference therein and any prospectus supplement deemed to be a part thereof. For purposes of this definition, information contained in
a form of prospectus that is deemed retroactively to be a part of the Registration Statement pursuant to Rule&nbsp;430B shall be considered
to be included in the Pricing Prospectus only if the actual time that form of prospectus is filed with the Commission pursuant to Rule&nbsp;424(b)&nbsp;is
prior to the Applicable Time.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;Trading Day&rdquo;
means a day on which the Trading Market is open for trading.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Each Issuer Free Writing
Prospectus, as of its issue date and at all subsequent times through the completion of the public offer and sale of the Shares or until
any earlier date that the issuer notified or notifies the Representative as described in the next sentence, did not, does not and will
not include any information that conflicted, conflicts or will conflict with the information contained in the Registration Statement
or the Prospectus, including any document incorporated by reference therein that has not been superseded or modified. If there occurs
an event or development as a result of which the General Disclosure Package would include an untrue statement of a material fact or would
omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances then prevailing, not
misleading, the Company will promptly notify the Representative so that any use of the General Disclosure Package may cease until it
is amended or supplemented to correct such untrue statement or omission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The foregoing representations
and warranties in this Section&nbsp;3(b)&nbsp;do not apply to any statements or omissions made in reliance on and in conformity with
information relating to any Underwriter furnished in writing to the Company by the Representative specifically for inclusion in the Registration
Statement, the Prospectus Supplement, the Pricing Prospectus, the Prospectus or any Issuer Free Writing Prospectus or any amendment or
supplement thereto. The Company acknowledges that the statements set forth in the second paragraph under the heading &ldquo;Underwriting&rdquo;
and the sections titled, &ldquo;Discretionary Accounts,&rdquo; &ldquo;Stabilization,&rdquo; &ldquo;Electronic Offer, Sale and Distribution
of Shares,&rdquo; and &ldquo;Other Relationships&rdquo; in the Pricing Prospectus and the Prospectus constitute the only information
relating to any Underwriter furnished in writing to the Company by the Representative specifically for inclusion in the Registration
Statement, the Prospectus Supplement, the Pricing Prospectus, the Prospectus and any Issuer Free Writing Prospectus.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">(i)&nbsp;At
the earliest time after the filing of the Registration Statement that the Company or another offering participant made a <I>bona fide
</I>offer (within the meaning of Rule&nbsp;164(h)(2)&nbsp;of the Rules&nbsp;and Regulations) of the Shares and (ii)&nbsp;as of the date
hereof, the Company was not and is not an Ineligible Issuer (as defined in Rule&nbsp;405 of the Rules&nbsp;and Regulations (&ldquo;Rule&nbsp;405&rdquo;)),
without taking account of any determination by the Commission pursuant to Rule&nbsp;405 that it is not necessary that the Company be
considered an Ineligible Issuer.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">All
of the direct and indirect subsidiaries (individually, a &ldquo;Subsidiary&rdquo;) of the Company are </FONT>disclosed in the <FONT STYLE="font-size: 10pt">Company&rsquo;s
most recent Annual Report on Form&nbsp;10-K filed with the Commission, excluding any entity that has been dissolved, is not in active
use by the Company, or does not otherwise constitute a significant subsidiary. The Company owns, directly or indirectly, all of the capital
stock or other equity interests of each Subsidiary free and clear of &ldquo;Liens&rdquo; (which for purposes of this Agreement shall
mean a lien, charge, security interest, encumbrance, right of first refusal, preemptive right or other restriction), and all of the issued
and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive
and similar rights to subscribe for or purchase securities.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized, validly existing and in good standing under
the laws of the jurisdiction of its incorporation or organization, with the requisite power and authority to own and use its properties
and assets and to carry on its business as currently conducted. Neither the Company nor any Subsidiary is in violation nor in default
of any of the provisions of its respective certificate or articles of incorporation, bylaws or other organizational or charter documents.
Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good standing as a foreign corporation or other
entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary,
except where the failure to be so qualified or in good standing, as the case may be, could not have or reasonably be expected to result
in: (i)&nbsp;a material adverse effect on the legality, validity or enforceability of this Agreement, (ii)&nbsp;a material adverse effect
on the results of operations, assets, business, prospects or condition (financial or otherwise) of the Company and the Subsidiaries,
taken as a whole, from that set forth in the Registration Statement, the Base Prospectus, any Prospectus Supplement, the Prospectus or
the SEC Reports, or (iii)&nbsp;a material adverse effect on the Company&rsquo;s ability to perform in any material respect on a timely
basis its obligations under this Agreement (any of (i), (ii)&nbsp;or (iii), a &ldquo;Material Adverse Effect&rdquo;) and no proceeding,
whether commenced or threatened, has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke,
limit or curtail such power and authority or qualification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated by this Agreement
and otherwise to carry out its obligations hereunder. The execution and delivery of this Agreement by the Company and the consummation
by it of the transactions contemplated hereby have been duly authorized by all necessary action on the part of the Company and no further
action is required by the Company, the Company&rsquo;s board of directors (the &ldquo;Board&rdquo;) or the Company&rsquo;s stockholders
in connection herewith other than in connection with the Required Approvals. This Agreement has been duly executed and delivered by the
Company and, when delivered in accordance with the terms hereof, will constitute the valid and binding obligation of the Company enforceable
against the Company in accordance with its terms, except (i)&nbsp;as limited by general equitable principles and applicable bankruptcy,
insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors&rsquo; rights generally,
(ii)&nbsp;as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and
(iii)&nbsp;insofar as indemnification and contribution provisions may be limited by applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
execution, delivery and performance by the Company of this Agreement, the sale of the Shares and the consummation of the transactions
contemplated hereby do not and will not (i)&nbsp;conflict with or violate any provision of the Company&rsquo;s or any Subsidiary&rsquo;s
certificate or articles of incorporation, bylaws or other organizational or charter documents, or (ii)&nbsp;conflict with, or constitute
a default (or an event that with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon
any of the properties or assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, anti-dilution
or similar adjustments, acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility,
debt or other instrument (evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary
is a party or by which any property or asset of the Company or any Subsidiary is bound or affected, or (iii)&nbsp;subject to the Required
Approvals, conflict with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction
of any court or governmental authority to which the Company or a Subsidiary is subject (including federal and state securities laws and
regulations), or by which any property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses
(ii)&nbsp;and (iii), such as could not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse
Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company is not required to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing or registration
with, any court or other federal, state, local or other governmental authority or other &ldquo;Person&rdquo; (defined as an individual
or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company, joint stock
company, government (or an agency or subdivision thereof) or other entity of any kind, including the Nasdaq Capital Market (the &ldquo;Trading
Market&rdquo;)) in connection with the purchase and distribution by the Underwriters of the Shares, other than (i)&nbsp;the filings required
by this Agreement, (ii)&nbsp;the filing with the Commission of the Prospectus Supplement, and (iii)&nbsp;such filings as are required
to be made under applicable state securities laws and the rules&nbsp;and regulations of the Financial Industry Regulatory Authority,&nbsp;Inc.
(&ldquo;FINRA&rdquo;) (collectively, the &ldquo;Required Approvals&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company has authorized, issued and outstanding capital stock as set forth under the caption &ldquo;Capitalization&rdquo; in the Pricing
Prospectus and the Prospectus as of the respective dates set forth therein. All of the outstanding shares of capital stock of the Company
(including the Firm Shares and the Option Shares to be sold by the Selling Stockholders under this Agreement) have been duly authorized,
validly issued and are fully paid and nonassessable and were issued in compliance with all applicable state and federal securities laws;
to the Company&rsquo;s knowledge, no preemptive or similar rights exist with respect to any of the Shares or the sale thereof. Upon receipt
of the Shares, the purchasers of such Shares will have good and marketable title to such Shares and the Shares will be freely tradable
on the Trading Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
description of the capital stock of the Company incorporated by reference in the Registration Statement, the Pricing Prospectus and the
Prospectus is complete and accurate in all respects. The Company has not issued any capital stock since its most recently filed periodic
report under the Exchange Act, other than pursuant to the exercise of employee stock options under the Company&rsquo;s stock option plans,
the issuance of shares of Common Stock to employees pursuant to the Company&rsquo;s employee stock purchase plan and pursuant to the
conversion and/or exercise of securities exercisable, exchangeable or convertible into Common Stock (&ldquo;Common Stock Equivalents&rdquo;)
outstanding as of the date of the most recently filed periodic report under the Exchange Act. No person has any right of first refusal,
preemptive right, right of participation, or any similar right to participate in the transactions contemplated by this Agreement. Except
as otherwise set forth in the Registration Statement, the Pricing Prospectus and the Prospectus, the Company does not have outstanding
and, at the Closing Date and, if later, the applicable Option Closing Date, will not have outstanding, any options, warrants, scrip rights
to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations convertible into
or exercisable or exchangeable for, or giving any person any right to subscribe for or acquire, any shares of Common Stock or the capital
stock of any Subsidiary, or contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may become
bound to issue additional shares of Common Stock or Common Stock Equivalents or capital stock of any Subsidiary. There are no outstanding
securities or instruments of the Company or any Subsidiary that contain any redemption or similar provisions, and there are no contracts,
commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to redeem a security of the
Company or such Subsidiary. The Company does not have any stock appreciation rights or &ldquo;phantom stock&rdquo; plans or agreements
or any similar plan or agreement. No further approval or authorization of any stockholder, the Board or others is required for the sale
of the Firm Shares and the Option Shares as contemplated herein. There are no stockholders agreements, voting agreements or other similar
agreements with respect to the Company&rsquo;s capital stock to which the Company is a party or, to the knowledge of the Company, between
or among any of the Company&rsquo;s stockholders. The certificates evidencing the Shares, if any, are in due and proper legal form.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Registration Statement is not the subject of a pending proceeding or examination under Section&nbsp;8(d)&nbsp;or 8(e)&nbsp;of the Act,
and the Company is not the subject of a pending proceeding under Section&nbsp;8A of the Act in connection with the offering of the Shares.
The Company has not received any notice that the Commission has issued or intends to issue a stop-order with respect to the Registration
Statement or that the Commission otherwise has suspended or withdrawn the effectiveness of the Registration Statement, either temporarily
or permanently, or intends or has threatened in writing to do so.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company has filed all SEC Reports required to be filed by the Company under the Act and the Exchange Act, including pursuant to Section&nbsp;13(a)&nbsp;or
15(d)&nbsp;thereof, for the two years preceding the date hereof (or such shorter period as the Company was required by law or regulation
to file such material) on a timely basis or has received a valid extension of such time of filing and has filed any such SEC Reports
prior to the expiration of any such extension. As of their respective dates, the SEC Reports complied in all material respects with the
requirements of the Act and the Exchange Act, as applicable, and none of the SEC Reports, when filed, contained any untrue statement
of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein,
in the light of the circumstances under which they were made, not misleading. The financial statements of the Company included in the
SEC Reports comply in all material respects with applicable accounting requirements and the rules&nbsp;and regulations of the Commission
with respect thereto as in effect at the time of filing. Such financial statements have been prepared in accordance with United States
generally accepted accounting principles applied on a consistent basis during the periods involved (&ldquo;GAAP&rdquo;), except as may
be otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements may not contain
all footnotes required by GAAP, and fairly present in all material respects the financial position of the Company and its consolidated
Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the
case of unaudited statements, to normal, immaterial, year-end audit adjustments. All disclosures regarding &ldquo;non-GAAP financial
measures&rdquo; comply with Regulation G of the Exchange Act and Item 10(e)&nbsp;of Regulation S-K under the Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Since
the date of the latest audited financial statements included within the SEC Reports, except as specifically disclosed in a subsequent
SEC Report filed prior to the date on which this representation is being made, (i)&nbsp;there has been no event, occurrence or development
that has had or that could reasonably be expected to result in a Material Adverse Effect, (ii)&nbsp;the Company has not incurred any
liabilities (contingent or otherwise) other than (A)&nbsp;trade payables and accrued expenses incurred in the ordinary course of business
consistent with past practice and (B)&nbsp;liabilities not required to be reflected in the Company&rsquo;s financial statements pursuant
to GAAP or disclosed in filings made with the Commission, (iii)&nbsp;the Company has not altered its method of accounting, (iv)&nbsp;the
Company has not declared or made any dividend or distribution of cash or other property to its stockholders or purchased, redeemed or
made any agreements to purchase or redeem any shares of its capital stock, (v)&nbsp;the Company has not issued any equity securities
to any officer, director or &ldquo;Affiliate&rdquo; (defined as any Person that, directly or indirectly through one or more intermediaries,
controls or is controlled by or is under common control with a Person, as such terms are used in and construed under Rule&nbsp;144 under
the Act), except pursuant to existing Company stock option plans, and (vi)&nbsp;no executive officer of the Company or member of the
Board has resigned from any position with the Company. The Company does not have pending before the Commission any request for confidential
treatment of information. Except for the sale of the Shares contemplated by this Agreement, no event, liability, fact, circumstance,
occurrence or development has occurred or exists or is reasonably expected to occur or exist with respect to the Company or its Subsidiaries
or their respective businesses, prospects, properties, operations, assets or financial condition that would be required to be disclosed
by the Company under applicable securities laws at the time this representation is made or deemed made that has not been publicly disclosed
at least one (1)&nbsp;Trading Day prior to the date that this representation is made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
as set forth in the SEC Reports, there is no action, suit, inquiry, notice of violation, proceeding or investigation pending or, to the
knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective properties before or
by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign) (collectively,
an &ldquo;Action&rdquo;). None of the Actions set forth in the SEC Reports, (i)&nbsp;adversely affects or challenges the legality, validity
or enforceability of this Agreement or the Shares or (ii)&nbsp;could, if there were an unfavorable decision, have or reasonably be expected
to result in a Material Adverse Effect. Neither the Company nor any Subsidiary, nor any director or officer thereof, is or has been the
subject of any Action involving a claim of violation of or liability under federal or state securities laws or a claim of breach of fiduciary
duty, which (i)&nbsp;adversely affects or challenges the legality, validity or enforceability of this Agreement or the Shares or (ii)&nbsp;would,
if there were an unfavorable decision, have or reasonably be expected to result in a Material Adverse Effect. There has not been, and
to the knowledge of the Company, there is not pending or contemplated, any investigation by the Commission involving the Company or any
current or former director or officer of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">No
labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees of the Company, which could
reasonably be expected to result in a Material Adverse Effect. None of the Company&rsquo;s or its Subsidiaries&rsquo; employees is a
member of a union that relates to such employee&rsquo;s relationship with the Company or such Subsidiary, and neither the Company nor
any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe that their relationships
with their employees are good. To the knowledge of the Company, no executive officer of the Company or any Subsidiary, is, or is now
expected to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary information
agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third party, and
the continued employment of each such executive officer does not subject the Company or any of its Subsidiaries to any liability with
respect to any of the foregoing matters. The Company and its Subsidiaries are in compliance with all applicable U.S. federal, state,
local and foreign laws and regulations relating to employment and employment practices, terms and conditions of employment and wages
and hours, except where the failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have a
Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Neither
the Company nor any Subsidiary: (i)&nbsp;is in default under or in violation of (and no event has occurred that has not been waived that,
with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor has the Company or any Subsidiary
received notice of a claim that it is in default under or that it is in violation of, any indenture, loan or credit agreement or any
other agreement or instrument to which it is a party or by which it or any of its properties is bound (whether or not such default or
violation has been waived), (ii)&nbsp;is in violation of any judgment, decree or order of any court, arbitrator or other governmental
authority or (iii)&nbsp;is or has been in violation of any statute, rule, ordinance or regulation of any governmental authority, including
without limitation all foreign, federal, state and local laws relating to taxes, environmental protection, occupational health and safety,
product quality and safety and employment and labor matters, except in each case as could not have or reasonably be expected to result
in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company and its Subsidiaries (i)&nbsp;are in compliance with all federal, state, local and foreign laws relating to pollution or protection
of human health or the environment (including ambient air, surface water, groundwater, land surface or subsurface strata), including
laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or toxic or hazardous
substances or wastes (collectively, &ldquo;Hazardous Materials&rdquo;) into the environment, or otherwise relating to the manufacture,
processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials, as well as all authorizations,
codes, decrees, demands, or demand letters, injunctions, judgments, licenses, notices or notice letters, orders, permits, plans or regulations,
issued, entered, promulgated or approved thereunder (&ldquo;Environmental Laws&rdquo;); (ii)&nbsp;have received all permits licenses
or other approvals required of them under applicable Environmental Laws to conduct their respective businesses; and (iii)&nbsp;are in
compliance with all terms and conditions of any such permit, license or approval where in each clause (i), (ii)&nbsp;and (iii), the failure
to so comply could be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate federal, state, local or
foreign regulatory authorities necessary to conduct their respective businesses as described in the SEC Reports, except where the failure
to possess such permits could not reasonably be expected to result in a Material Adverse Effect (&ldquo;Material Permits&rdquo;), and
neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation or modification of any Material
Permit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by them and good and marketable
title in all personal property owned by them that is material to the business of the Company and the Subsidiaries, in each case free
and clear of all Liens, except for (i)&nbsp;Liens as do not materially affect the value of such property and do not materially interfere
with the use made and proposed to be made of such property by the Company and the Subsidiaries and (ii)&nbsp;Liens for the payment of
federal, state or other taxes, for which appropriate reserves have been made therefor in accordance with GAAP and, the payment of which
is neither delinquent nor subject to penalties. Any real property and facilities held under lease by the Company and the Subsidiaries
are held by them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in compliance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks, trademark applications, service
marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and similar rights necessary
or required for use in connection with their respective businesses as described in the SEC Reports and which the failure to so have could
have a Material Adverse Effect (collectively, the &ldquo;Intellectual Property Rights&rdquo;). None of, and neither the Company nor any
Subsidiary has received a notice (written or otherwise) that any of, the Intellectual Property Rights has expired, terminated or been
abandoned, or is expected to expire or terminate or be abandoned, within two (2)&nbsp;years from the date of this Agreement, except as
could not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. Neither the Company nor any Subsidiary
has received, since the date of the latest audited financial statements included within the SEC Reports, a written notice of a claim
or otherwise has any knowledge that the Intellectual Property Rights violate or infringe upon the rights of any Person, except as could
not have or reasonably be expected to not have a Material Adverse Effect. To the knowledge of the Company, all Intellectual Property
Rights are enforceable and there is no existing infringement by another Person of any of the Intellectual Property Rights. The Company
and its Subsidiaries have taken reasonable security measures to protect the secrecy, confidentiality and value of all of their intellectual
properties, except where failure to do so could not, individually or in the aggregate, reasonably be expected to have a Material Adverse
Effect. The Company owns or has a valid right to access and use all computer systems, networks, hardware, software, databases, websites,
and equipment used to process, store, maintain, and operate data.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in such
amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged, including, but not limited
to, directors and officers insurance coverage. Neither the Company nor any Subsidiary has any reason to believe that it will not be able
to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may
be necessary to continue its business without a significant increase in cost.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
as set forth in the SEC Reports, none of the officers or directors of the Company or any Subsidiary and, to the knowledge of the Company,
none of the employees of the Company or any Subsidiary is presently a party to any transaction with the Company or any Subsidiary (other
than for services as employees, officers and directors), including any contract, agreement or other arrangement providing for the furnishing
of services to or by, providing for rental of real or personal property to or from, providing for the borrowing of money from or lending
of money to or otherwise requiring payments to or from any officer, director or such employee or, to the knowledge of the Company, any
entity in which any officer, director, or any such employee has a substantial interest or is an officer, director, trustee, stockholder,
member or partner, in each case in excess of $120,000 other than for (i)&nbsp;payment of salary or consulting fees for services rendered,
(ii)&nbsp;reimbursement for expenses incurred on behalf of the Company and (iii)&nbsp;other employee benefits, including stock option
agreements under any stock option plan of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company and the Subsidiaries are in compliance with any and all applicable requirements of the Sarbanes-Oxley Act of 2002, as amended,
that are effective as of the date hereof, and any and all applicable rules&nbsp;and regulations promulgated by the Commission thereunder
that are effective as of the date hereof. The Company and the Subsidiaries maintain a system of internal accounting controls sufficient
to provide reasonable assurance that: (i)&nbsp;transactions are executed in accordance with management&rsquo;s general or specific authorizations,
(ii)&nbsp;transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain
asset accountability, (iii)&nbsp;access to assets is permitted only in accordance with management&rsquo;s general or specific authorization,
and (iv)&nbsp;the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action
is taken with respect to any differences. The Company and the Subsidiaries have established disclosure controls and procedures (as defined
in Exchange Act Rules&nbsp;13a-15(e)&nbsp;and 15d-15(e)) for the Company and the Subsidiaries and designed such disclosure controls and
procedures to ensure that information required to be disclosed by the Company in the reports it files or submits under the Exchange Act
is recorded, processed, summarized and reported, within the time periods specified in the Commission&rsquo;s rules&nbsp;and forms. The
Company&rsquo;s certifying officers have evaluated the effectiveness of the disclosure controls and procedures of the Company and the
Subsidiaries as of the end of the period covered by the most recently filed periodic report under the Exchange Act (such date, the &ldquo;Evaluation
Date&rdquo;). The Company presented in its most recently filed periodic report under the Exchange Act the conclusions of the certifying
officers about the effectiveness of the disclosure controls and procedures based on their evaluations as of the Evaluation Date. Since
the Evaluation Date, there have been no changes in the internal control over financial reporting (as such term is defined in the Exchange
Act) of the Company and its Subsidiaries that have materially affected, or is reasonably likely to materially affect, the internal control
over financial reporting of the Company and its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Other
than as contemplated by this Agreement, the Company has not incurred and will not incur any liability for any finder&rsquo;s or broker&rsquo;s
fee or agent&rsquo;s commission in connection with the execution and delivery of this Agreement or the consummation of the transactions
contemplated hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company is not, and is not an Affiliate of, and as a result of the transactions contemplated hereby, will not be or be an Affiliate of,
an &ldquo;investment company&rdquo; within the meaning of the Investment Company Act of 1940, as amended. The Company shall conduct its
business in a manner so that it will not become an &ldquo;investment company&rdquo; subject to registration under the Investment Company
Act of 1940, as amended. The Company shall conduct its business in a manner so as to reasonably ensure that it or its Subsidiaries will
not become an &ldquo;investment company&rdquo; subject to registration under the Investment Company Act of 1940, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Shares to be sold by the Selling Stockholders hereunder are listed on the Trading Market and the sale of the Shares by the Selling Stockholders
as contemplated by this Agreement does not contravene the rules&nbsp;and regulations of the Trading Market. The Common Stock is registered
pursuant to Section&nbsp;12(b)&nbsp;or 12(g)&nbsp;of the Exchange Act, and the Company has taken no action designed to, or which to its
knowledge is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act nor has the Company
received any notification that the Commission is contemplating terminating such registration. The Company has not, in the 12 months preceding
the date hereof, received notice from any Trading Market on which the Common Stock is or has been listed or quoted to the effect that
the Company is not in compliance with the listing or maintenance requirements of such Trading Market. The Company is, and has no reason
to believe that it will not in the foreseeable future continue to be, in compliance with all such listing and maintenance requirements.
The Common Stock is currently eligible for electronic transfer through the Depository Trust Company or another established clearing corporation
and the Company is current in payment of the fees to the Depository Trust Company (or such other established clearing corporation) in
connection with such electronic transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aa)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company and the Board have taken all necessary action, if any, in order to render inapplicable any control share acquisition, business
combination, poison pill (including any distribution under a rights agreement) or other similar anti-takeover provision under the Company&rsquo;s
certificate of incorporation (or similar charter documents) or the laws of its state of incorporation that is or could become applicable
to the Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(bb)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Based
on the consolidated financial condition of the Company as of the date hereof, (i)&nbsp;the fair saleable value of the Company&rsquo;s
assets exceeds the amount that will be required to be paid on or in respect of the Company&rsquo;s existing debts and other liabilities
(including known contingent liabilities) as they mature, (ii)&nbsp;the Company&rsquo;s assets do not constitute unreasonably small capital
to carry on its business as now conducted and as proposed to be conducted including its capital needs taking into account the particular
capital requirements of the business conducted by the Company, consolidated and projected capital requirements and capital availability
thereof, and (iii)&nbsp;the current cash flow of the Company, together with the proceeds the Company would receive, were it to liquidate
all of its assets, after taking into account all anticipated uses of the cash, would be sufficient to pay all amounts on or in respect
of its liabilities when such amounts are required to be paid. The Company does not intend to incur debts beyond its ability to pay such
debts as they mature (taking into account the timing and amounts of cash to be payable on or in respect of its debt) within one year
from the date hereof. The Company has no knowledge of any facts or circumstances which lead it to believe that it will file for reorganization
or liquidation under the bankruptcy or reorganization laws of any jurisdiction within one year from the date hereof. The SEC Reports
set forth as of the date hereof all outstanding secured and unsecured Indebtedness of the Company or any Subsidiary, or for which the
Company or any Subsidiary has commitments. Neither the Company nor any Subsidiary is in default with respect to any Indebtedness. For
the purposes of this Agreement, &ldquo;Indebtedness&rdquo; means (x)&nbsp;any liabilities for borrowed money or amounts owed in excess
of $50,000 (other than trade accounts payable incurred in the ordinary course of business), (y)&nbsp;all guaranties, endorsements and
other contingent obligations in respect of indebtedness of others, whether or not the same are or should be reflected in the Company&rsquo;s
consolidated balance sheet (or the notes thereto), except guaranties by endorsement of negotiable instruments for deposit or collection
or similar transactions in the ordinary course of business; and (z)&nbsp;the present value of any lease payments in excess of $50,000
due under leases required to be capitalized in accordance with GAAP.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(cc)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect,
the Company and its Subsidiaries each (i)&nbsp;has made or filed all United States federal, state and local income and all foreign income
and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii)&nbsp;has paid all taxes
and other governmental assessments and charges that are material in amount, shown or determined to be due on such returns, reports and
declarations and (iii)&nbsp;has set aside on its books provision reasonably adequate for the payment of all material taxes for periods
subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material amount claimed
to be due by the taxing authority of any jurisdiction, and the officers of the Company or of any Subsidiary know of no basis for any
such claim.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(dd)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Neither
the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any agent or other person acting on behalf of
the Company or any Subsidiary, has (i)&nbsp;directly or indirectly, used any funds for unlawful contributions, gifts, entertainment or
other unlawful expenses related to foreign or domestic political activity, (ii)&nbsp;made any unlawful payment to foreign or domestic
government officials or employees or to any foreign or domestic political parties or campaigns from corporate funds, (iii)&nbsp;failed
to disclose fully any contribution made by the Company or any Subsidiary (or made by any person acting on its behalf of which the Company
is aware) which is in violation of law, or (iv)&nbsp;violated in any material respect any provision of the Foreign Corrupt Practices
Act of 1977, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ee)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company&rsquo;s accounting firm is set forth in the SEC Reports. To the knowledge and belief of the Company, such accounting firm (i)&nbsp;is
a registered public accounting firm as required by the Exchange Act and (ii)&nbsp;shall express its opinion with respect to the financial
statements to be included in the next Annual Report of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ff)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company has not distributed and will not distribute prior to the later of (i)&nbsp;the Closing Date or, if later, the applicable Option
Closing Date, and (ii)&nbsp;completion of the distribution of the Shares, any offering material in connection with the offering and sale
of the Shares other than any preliminary prospectuses, the Prospectus, the Registration Statement, any Issuer Free Writing Prospectus
listed in Schedule III hereto, and other materials, if any, permitted by the Act and the Rules&nbsp;and Regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(gg)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company has not, and to its knowledge no one acting on its behalf has, (i)&nbsp;taken, directly or indirectly, any action designed to
cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale
of any of the Shares, (ii)&nbsp;sold, bid for, purchased, or, paid any compensation for soliciting purchases of, any of the Shares, or
(iii)&nbsp;paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities of the Company,
other than, in the case of clauses (ii)&nbsp;and (iii), as otherwise disclosed in this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(hh)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Each
stock option granted by the Company under the Company&rsquo;s stock option plan was granted (i)&nbsp;in accordance with the terms of
the Company&rsquo;s stock option plan and (ii)&nbsp;with an exercise price at least equal to the fair market value of the Common Stock
on the date such stock option would be considered granted under GAAP and applicable law. No stock option granted under the Company&rsquo;s
stock option plan has been backdated. The Company has not knowingly granted, and there is no and has been no Company policy or practice
to knowingly grant, stock options prior to, or otherwise knowingly coordinate the grant of stock options with, the release or other public
announcement of material information regarding the Company or its Subsidiaries or their financial results or prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">(i)(x)&nbsp;There
has been no material security breach or other compromise of or relating to any of the Company&rsquo;s or any Subsidiary&rsquo;s information
technology and computer systems, networks, hardware, software, data (including the data of its respective customers, employees, suppliers,
vendors and any third party data maintained by or on behalf of it), equipment or technology (collectively, &ldquo;IT Systems and Data&rdquo;)
and (y)&nbsp;the Company and the Subsidiaries have not been notified of, and has no knowledge of any event or condition that would reasonably
be expected to result in, any material security breach or other compromise to its IT Systems and Data; (ii)&nbsp;the Company and the
Subsidiaries are presently in compliance with all applicable laws or statutes and all judgments, orders, rules&nbsp;and regulations of
any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy
and security of IT Systems and Data and to the protection of such IT Systems and Data from unauthorized use, access, misappropriation
or modification, except as would not, individually or in the aggregate, have a Material Adverse Effect; (iii)&nbsp;the Company and the
Subsidiaries have implemented and maintained commercially reasonable safeguards to maintain and protect its material confidential information
and the integrity, continuous operation, redundancy and security of all IT Systems and Data; and (iv)&nbsp;the Company and the Subsidiaries
have implemented backup and disaster recovery technology consistent with industry standards and practices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(jj)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">(i)&nbsp;The
Company and the Subsidiaries are, and at all times during the past three years were, in compliance with all applicable data privacy and
security laws and regulations, including, as applicable, the European Union General Data Protection Regulation (&ldquo;GDPR&rdquo;) (EU
2016/679) (collectively, &ldquo;Privacy Laws&rdquo;); (ii)&nbsp;the Company and the Subsidiaries have in place, comply with, and take
appropriate steps reasonably designed to ensure compliance with their policies and procedures relating to data privacy and security and
the collection, storage, use, disclosure, handling and analysis of Personal Data (the &ldquo;Policies&rdquo;); (iii)&nbsp;the Company
provides accurate notice of its applicable Policies to its customers, employees, third party vendors and representatives as required
by Privacy Laws; and (iv)&nbsp;applicable Policies provide accurate and sufficient notice of the Company&rsquo;s then-current privacy
practices relating to its subject matter, and do not contain any material omissions of the Company&rsquo;s then-current privacy practices,
as required by Privacy Laws, except, in each case, such as would not have or reasonably be expected to result in a Material Adverse Effect.
 &ldquo;Personal Data&rdquo; means (i)&nbsp;a natural person&rsquo;s name, street address, telephone number, email address, photograph,
social security number, bank information, or customer or account number; (ii)&nbsp;any information which would qualify as &ldquo;personally
identifying information&rdquo; under the Federal Trade Commission Act, as amended; (iii)&nbsp;&ldquo;personal data&rdquo; as defined
by GDPR; and (iv)&nbsp;any other piece of information that allows the identification of such natural person, or his or her family, or
permits the collection or analysis of any identifiable data related to an identified person&rsquo;s health or sexual orientation. (i)&nbsp;None
of such disclosures made or contained in any of the Policies have been inaccurate, misleading, or deceptive in violation of any Privacy
Laws and (ii)&nbsp;the execution, delivery and performance of this Agreement will not result in a breach of any Privacy Laws or Policies,
except, in each case, such as would not have or reasonably be expected to result in a Material Adverse Effect. Neither the Company nor
the Subsidiaries, (i)&nbsp;has, to the knowledge of the Company, received written notice of any actual or potential liability of the
Company or the Subsidiaries under, or actual or potential violation by the Company or the Subsidiaries of, any of the Privacy Laws; (ii)&nbsp;is
currently conducting or paying for, in whole or in part, any investigation, remediation or other corrective action pursuant to any regulatory
request or demand pursuant to any Privacy Law; or (iii)&nbsp;is a party to any order, decree, or agreement by or with any court or arbitrator
or governmental or regulatory authority that imposed any obligation or liability under any Privacy Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(kk)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Neither
the Company nor any of its Subsidiaries, nor to the knowledge of the Company, any of the directors, officers or employees of the Company
or its Subsidiaries, is an individual or entity that is, or is owned or controlled by an individual or entity that is: (i)&nbsp;the subject
of any sanctions administered or enforced by the U.S. Department of Treasury&rsquo;s Office of Foreign Assets Control, the United Nations
Security Council, the European Union, Her Majesty&rsquo;s Treasury, or other relevant sanctions authority (collectively, &ldquo;Sanctions&rdquo;),
nor (ii)&nbsp;located, organized or resident in a country or territory that is the subject of Sanctions. Neither the Company nor any
of its Subsidiaries will, directly or indirectly, use the proceeds of the transactions contemplated hereby, or lend, contribute or otherwise
make available such proceeds to any Subsidiary, joint venture partner or other individual or entity: (i)&nbsp;to fund or facilitate any
activities or business of or with any individual or entity or in any country or territory that, at the time of such funding or facilitation,
is the subject of Sanctions or (ii)&nbsp;in any other manner that will result in a violation of Sanctions by any individual or entity
(including any individual or entity participating in the transactions contemplated hereby, whether as underwriter, advisor, investor
or otherwise). For the past five years, neither the Company nor any of its Subsidiaries has knowingly engaged in, and is not now knowingly
engaged in, any dealings or transactions with any individual or entity, or in any country or territory, that at the time of the dealing
or transaction is or was the subject of Sanctions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ll)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company is not and has never been a U.S. real property holding corporation within the meaning of Section&nbsp;897 of the Internal Revenue
Code of 1986, as amended, and the Company shall so certify upon the Underwriters&rsquo; request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(mm)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Neither
the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company Act of 1956, as amended (the &ldquo;BHCA&rdquo;)
and to regulation by the Board of Governors of the Federal Reserve System (the &ldquo;Federal Reserve&rdquo;). Neither the Company nor
any of its Subsidiaries or Affiliates owns or controls, directly or indirectly, five percent (5%) or more of the outstanding shares of
any class of voting securities or twenty-five percent (25%) or more of the total equity of a bank or any entity that is subject to the
BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries or Affiliates exercises a controlling
influence over the management or policies of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(nn)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with applicable financial record-keeping
and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, applicable money laundering statutes
and applicable rules&nbsp;and regulations thereunder (collectively, the &ldquo;Money Laundering Laws&rdquo;), and no Action or proceeding
by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any Subsidiary with respect
to the Money Laundering Laws is pending or, to the knowledge of the Company or any Subsidiary, threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(oo)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">There
are no affiliations with any FINRA member firm among the Company&rsquo;s officers, directors or, to the knowledge of the Company, any
five percent (5%) or greater stockholder of the Company, except as set forth in the Registration Statement, the Base Prospectus, any
Prospectus Supplement or the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><I>Representations,
Warranties and Covenants of the Selling Stockholders.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Each
Selling Stockholder, severally and not jointly, represents, warrants and covenants to each</FONT> Underwriter that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">All
consents, approvals, authorizations and orders necessary for the execution and delivery by such Selling Stockholder of this Agreement
and for the sale and delivery of the Shares to be sold by the Selling Stockholder hereunder, have been obtained; and such Selling Stockholder
has full right, power and authority to enter into this Agreement and to sell, assign, transfer and deliver the Shares to be sold by such
Selling Stockholder hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
execution and delivery by such Selling Stockholder of this Agreement, and the consummation of the transactions herein contemplated will
not (i)&nbsp;conflict with or result in a breach or violation of any of the terms or provisions of, or constitute a default under, any
indenture, mortgage, deed of trust, loan agreement, lease or other agreement or instrument to which the Selling Stockholder is a party
or by which the Selling Stockholder is bound or to which any of the property or assets of the Selling Stockholder is subject, except
where such breach, violation or default as would not impair in any material respects the consummation of the Selling Stockholder&rsquo;s
obligations under this Agreement, or any statute or any order, rule&nbsp;or regulation of any court or governmental agency or body having
jurisdiction over the Selling Stockholder or any property or assets of the Selling Stockholder; and (ii)&nbsp;no consent, approval, authorization,
order, registration or qualification of or with any such court or governmental body or agency is required for the performance by the
Selling Stockholder of its obligations under this Agreement and the consummation by the Selling Stockholder of the transactions contemplated
by this Agreement in connection with the Shares to be sold by the Selling Stockholder hereunder, except the registration under the Securities
Act of the Shares, the approval by FINRA of the underwriting terms and arrangements and such consents, approvals, authorizations, orders,
registrations or qualifications as may be required under state securities or Blue Sky laws in connection with the purchase and distribution
of the Shares by the Underwriters and where the failure to obtain such consent, approval, authorization or order or to make such filing
or registration would not reasonably be expected to (1)&nbsp;have a Material Adverse Effect or (2)&nbsp;materially and adversely affect
the ability of the Selling Stockholder to perform its obligations under this Agreement or to consummate the transactions contemplated
by the Registration Statement, the General Disclosure Package and the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
sale of the Shares by such Selling Stockholder hereunder and the performance by such Selling Stockholder of its obligations under this
Agreement and the consummation of the transactions contemplated hereby and thereby will not (i)&nbsp;result in the creation or imposition
of any lien, charge or encumbrance upon any of the assets of such Selling Stockholder pursuant to the terms or provisions of, or result
in a breach or violation of any of the terms or provisions of, or constitute a default under, or give any party a right to terminate
any of its obligations under, or result in the acceleration of any obligation under, any indenture, mortgage, deed of trust, voting trust
agreement, loan agreement, bond, debenture, note agreement or other evidence of indebtedness, lease, contract or other agreement or instrument
to which such Selling Stockholder is a party or by which such Selling Stockholder or any of its properties is bound or affected, (ii)&nbsp;violate
or conflict with any judgment, ruling, decree, order, statute, rule&nbsp;or regulation of any court or other governmental agency or body
applicable to such Selling Stockholder or (iii)&nbsp;if such Selling Stockholder is a corporation, partnership or other entity, violate
or conflict with the organizational documents of such Selling Stockholder (except in the case of clauses (i)&nbsp;and (ii)&nbsp;where
such conflict, breach, violation, lien, charge, encumbrance or default, as applicable, would not materially adversely affect the ability
of the Selling Stockholder to consummate the transactions contemplated by the Agreement).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Such
Selling Stockholder has, and at the Closing Date and, if later, the applicable Option Closing Date, will have, good and marketable title
to the Shares to be sold by such Selling Stockholder hereunder, whether held in certificated form, book-entry form of in brokerage accounts,
free and clear of all liens, encumbrances, equities or claims whatsoever; and, upon delivery of such Shares and payment therefor pursuant
hereto, good and marketable title to such Shares, free and clear of all liens, encumbrances, equities or claims whatsoever, will be delivered
to the Underwriters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">To
the extent that any of the Firm Shares or the Option Shares are held in certificated form, upon payment of the purchase price for such
Shares, delivery of such Shares, as directed by the Representative, to Cede&nbsp;&amp; Co. (&ldquo;Cede&rdquo;) or such other nominee
as may be designated by DTC (unless delivery of such Shares is unnecessary because such Shares are already in possession of Cede or such
nominee), registration of such Shares in the name of Cede or such other nominee (unless registration of such Shares is unnecessary because
such Shares are already registered in the name of Cede or such nominee), and the crediting of such Shares on the books of DTC to &ldquo;securities
accounts&rdquo; (within the meaning of Section&nbsp;8-501(a)&nbsp;of the Uniform Commercial Code then in effect in the State of New York
(&ldquo;UCC&rdquo;)) of the Underwriters (assuming that neither DTC nor such Representative has notice of any &ldquo;adverse claim&rdquo;
(within the meaning of Section&nbsp;8-105 of the UCC) to such Shares), (x)&nbsp;under Section&nbsp;8-501 of the UCC, the Underwriters
will acquire a valid &ldquo;security entitlement&rdquo; (as defined in Section&nbsp;8-102 of the UCC) in respect of such Shares and (y)&nbsp;no
action (whether framed in conversion, replevin, constructive trust, equitable lien, or other theory) based on an &ldquo;adverse claim&rdquo;
(within the meaning of Section&nbsp;8-102 of the UCC) to such Shares may be asserted against the Underwriters with respect to such security
entitlement. For purposes of this representation, such Selling Stockholder may assume that when such payment, delivery (if necessary)
and crediting occur, (u)&nbsp;such Shares will have been registered in the name of Cede or another nominee designated by DTC, in each
case, on the Company&rsquo;s share registry in accordance with its certificate of incorporation, bylaws and applicable law, (v)&nbsp;DTC
will be registered as a &ldquo;clearing corporation&rdquo; (within the meaning of Section&nbsp;8-102 of the UCC), (w)&nbsp;appropriate
entries to the accounts of the several Underwriters on the records of DTC will have been made pursuant to the UCC, (x)&nbsp;to the extent
DTC, or any other securities intermediary which acts as &ldquo;clearing corporation&rdquo; with respect to the Shares, maintains any
 &ldquo;financial asset&rdquo; (as defined in Section&nbsp;8-102(a)(9)&nbsp;of the UCC) in a clearing corporation pursuant to Section&nbsp;8-111
of the UCC, the rules&nbsp;of such clearing corporation may affect the rights of DTC or such securities intermediaries and the ownership
interest of the Underwriters, (y)&nbsp;claims of creditors of DTC or any other securities intermediary or clearing corporation may be
given priority to the extent set forth in Section&nbsp;8-511(b)&nbsp;and 8-511(c)&nbsp;of the UCC and (z)&nbsp;if at any time DTC or
other securities intermediary does not have sufficient Shares to satisfy claims of all of its entitlement holders with respect thereto,
then all holders will share pro rata in the Shares then held by DTC or such securities intermediary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Any
Shares held in certificated form to be sold by such Selling Stockholder are in registered form and are not held in any securities account
or by or through any securities intermediary within the meaning of the UCC. Certificates for all such certificated Shares to be sold
by such Selling Stockholder, in suitable form for transfer by delivery or accompanied by duly executed instruments of transfer or assignment
in blank with signatures guaranteed, shall be delivered to the transfer agent for the Shares pursuant to this Agreement prior to the
applicable Closing Date or, if later, the applicable Option Closing Date, as the case may be.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">On
the Closing Date or, if later, the applicable Option Closing Date, all stock transfer or other taxes (other than income taxes) that are
required to be paid in connection with the sale and transfer of the Shares to be sold by such Selling Stockholder to the several Underwriters
hereunder will have been fully paid or provided for by such Selling Stockholder and all laws imposing such taxes will have been fully
complied with.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Other
than as permitted by the Act and the Rules&nbsp;and Regulations, such Selling Stockholder has not distributed and will not distribute
any preliminary prospectus, the Prospectus or any other offering material in connection with the offering and sale of the Shares. Such
Selling Stockholder has not taken and will not take on or prior to the date 30 days after the date hereof, directly or indirectly, any
action designed, or that might reasonably be expected, to cause or result in, or that will constitute, stabilization of the price of
shares of Common Stock to facilitate the sale or resale of any of the Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">All
information with respect to such Selling Stockholder contained in the Registration Statement, any preliminary prospectus, the Pricing
Prospectus, the Prospectus or any amendment or supplement thereto does not and will not contain any untrue statement of a material fact
or omit to state any material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances
under which these were made, not misleading; provided, however, that the representations and warranties made in this Section&nbsp;4(i)&nbsp;by
each Selling Stockholder are limited to statements or omissions made in reliance upon and in conformity with information relating to
such Selling Stockholder furnished to the Company or any of the Underwriters in writing by or on behalf of such Selling Stockholder expressly
for use in the Registration Statement, any preliminary prospectus, the Pricing Prospectus, the Prospectus Supplement, the Prospectus,
any Issuer Free Writing Prospectus or any amendment or supplement thereto (such information, the &ldquo;Selling Stockholder Information&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">As
of the date hereof, the Closing Date and the applicable Option Closing Date, as the case may be, such Selling Stockholder is not and
will not be prompted by any material information concerning the Company or its subsidiaries which is not set forth in the Registration
Statement, the General Disclosure Package and the Prospectus to sell its Shares pursuant to this&nbsp;Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">In
order to document the Underwriters&rsquo; compliance with the reporting and withholding provisions of the Tax Equity and Fiscal Responsibility
Act of 1982 with respect to the transactions herein contemplated, such Selling Stockholder agrees to deliver to you prior to or at the
Closing Date a properly completed and executed United States Treasury Department Form&nbsp;W-9 (or other applicable form or statement
specified by Treasury Department regulations in lieu thereof).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Such
Selling Stockholder, directly or indirectly, has not entered into any commitment, transaction, or other arrangement, including any prepaid
forward contract, 10b5-1 plan or similar agreement, that transfers or may transfer any of the legal or beneficial ownership or any of
the economic consequences of ownership of the Shares, except as has been previously disclosed to the Representative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
as disclosed in the Registration Statement, the General Disclosure Package and the Prospectus, Such Selling Stockholder is not a party
to any contract,&nbsp;agreement&nbsp;or understanding with any person (other than this&nbsp;Agreement) that would give rise to a valid
claim against any of them or any&nbsp;Underwriter&nbsp;for a brokerage commission, finder&rsquo;s fee or like payment in connection with
the offering and sale of the Firm Shares or the Option Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Without
having undertaken to determine independently the accuracy or completeness of either the representations and warranties of the Company
contained herein or the information contained in the Registration Statement, the General Disclosure Package and the Prospectus, such
Selling Stockholder (x)&nbsp;has no reason to believe that the representations and warranties of the Company contained in Section&nbsp;3
hereof are not true and correct, (y)&nbsp;is familiar with the Registration Statement, the General Disclosure Package and the Prospectus
and (z)&nbsp;has no knowledge of any material fact, condition or information not disclosed in the Registration Statement, the General
Disclosure Package and the Prospectus, which has materially adversely affected or may materially adversely affect the business of the
Company or any of its subsidiaries. Any certificate signed on behalf of a Selling Stockholder and delivered to the Underwriters or to
counsel for the Underwriters shall be deemed to be a representation and warranty by such Selling Stockholder to the Underwriters as to
the matters set forth therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><I>Agreements
of the Company and the Selling Stockholders</I>.Each of the Company or the Selling Stockholders, as applicable, covenants and agrees
with the several Underwriters as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company will not, either prior to the Applicable Time or thereafter during such period as the Prospectus is required by law to be delivered
in connection with sales of the Shares by an Underwriter or a dealer, file any amendment or supplement to the Registration Statement,
the Base Prospectus or the Prospectus, unless a copy thereof shall first have been submitted to the Representative within a reasonable
period of time prior to the filing thereof and the Representative shall not have objected thereto in good faith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company will notify the Representative promptly, and will confirm such advice in writing, (i)&nbsp;when any amendment to the Registration
Statement has been filed or becomes effective or any amendment or supplement to the Prospectus has been filed, (ii)&nbsp;of any request
by the Commission for amendments or supplements to the Registration Statement or the Prospectus or for additional information, (iii)&nbsp;of
the issuance by the Commission of any stop order suspending the effectiveness of the Registration Statement or preventing or suspending
the use of the Base Prospectus, any preliminary prospectus, the Prospectus Supplement, the Prospectus or any Issuer Free Writing Prospectus
or the initiation of any proceedings for that purpose or the threat thereof, (iv)&nbsp;of the happening of any event during the period
mentioned in the third sentence of Section&nbsp;5(e)&nbsp;that in the judgment of the Company makes any statement made in the Registration
Statement or the Prospectus untrue or that requires the making of any changes in the Registration Statement or the Prospectus in order
to make the statements therein, in the light of the circumstances in which they are made, not misleading, and (v)&nbsp;of receipt by
the Company or any representative or attorney of the Company of any other communication from the Commission relating to the Company,
the Registration Statement, any preliminary prospectus, the Base Prospectus, the Prospectus Supplement or the Prospectus. If at any time
the Commission shall issue any order suspending the effectiveness of the Registration Statement or preventing or suspending the use of
the Base Prospectus, any preliminary prospectus, the Prospectus Supplement, the Prospectus or any Issuer Free Writing Prospectus, the
Company will make every reasonable effort to obtain the withdrawal of such order at the earliest possible moment. If the Company has
omitted any information from the Registration Statement pursuant to Rule&nbsp;430B of the Rules&nbsp;and Regulations, the Company will
comply with the provisions of and make all requisite filings with the Commission pursuant to said Rule&nbsp;430B and notify the Representative
promptly of all such filings. If the Company elects to rely upon Rule&nbsp;462(b)&nbsp;under the Act, the Company shall file a registration
statement under Rule&nbsp;462(b)&nbsp;with the Commission in compliance with Rule&nbsp;462(b)&nbsp;by 10:00 p.m., Washington, D.C. time,
on the date of this Agreement, and the Company shall at the time of filing either pay to the Commission the filing fee for such Rule&nbsp;462(b)&nbsp;registration
statement or give irrevocable instructions for the payment of such fee pursuant to the Rules&nbsp;and Regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company will furnish to each Representative, without charge, an electronic copy of each of the Registration Statement and of any pre-
or post-effective amendment thereto, including financial statements and schedules, and all exhibits thereto and will furnish to the Representative,
without charge, for transmittal to each of the other Underwriters, a copy of the Registration Statement and any pre- or post-effective
amendment thereto, including financial statements and schedules but without exhibits.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company will comply with all the provisions of any undertakings contained in the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">So
long as delivery of a prospectus by an Underwriter or dealer may be required by the Act (including in circumstances where such requirement
may be satisfied pursuant to Rule&nbsp;172 of the Rules&nbsp;and Regulations), the Company will deliver to each of the Underwriters,
without charge, as many written and electronic copies of each preliminary prospectus, the Base Prospectus, the Prospectus Supplement,
the Prospectus, each Issuer Free Writing Prospectus or any amendment or supplement thereto as the Representative may reasonably request.
The Company and the Selling Stockholders consent to the use of each preliminary prospectus, the Base Prospectus, the Prospectus Supplement,
the Prospectus, each Issuer Free Writing Prospectus and any amendment or supplement thereto by the Underwriters and by all dealers to
whom the Shares may be sold, both in connection with the offering or sale of the Shares and for any period of time thereafter during
which the Prospectus is required by law to be delivered in connection therewith. If during such period of time any event shall occur
that in the judgment of the Company or counsel to the Underwriters should be set forth in the Prospectus in order to make any statement
therein, in the light of the circumstances under which it was made, not misleading, or if it is necessary to supplement or amend the
Prospectus to comply with law, the Company will forthwith prepare and duly file with the Commission an appropriate supplement or amendment
thereto, and will deliver to each of the Underwriters, without charge, such number of copies of such supplement or amendment to the Prospectus
as the Representative may reasonably request. The Company will not file any document under the Exchange Act or the Exchange Act Rules&nbsp;and
Regulations before the termination of the offering of the Shares by the Underwriters, if such document would be deemed to be incorporated
by reference into the Prospectus, that is not approved by the Representative after reasonable notice thereof. If at any time following
issuance of an Issuer Free Writing Prospectus there occurred or occurs an event or development as a result of which such Issuer Free
Writing Prospectus conflicted or would conflict with the information contained in the Registration Statement, the Pricing Prospectus
or the Prospectus or included or would include an untrue statement of a material fact or omitted or would omit to state a material fact
necessary in order to make the statements therein, in the light of the circumstances prevailing at that subsequent time, not misleading,
the Company will promptly notify the Representative and, if requested by the Representative, will promptly amend or supplement, at its
own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement or omission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Prior
to any public offering of the Shares, the Company will cooperate with the Representative and counsel to the Underwriters in connection
with the registration or qualification of the Shares for offer and sale under the state or foreign securities or Blue Sky laws of such
jurisdictions as the Representative may request; provided, that in no event shall the Company be obligated to qualify to do business
in any jurisdiction where it is not now so qualified or to take any action that would subject it to general service of process in any
jurisdiction where it is not now so subject.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company will, so long as required under the Rules&nbsp;and Regulations, furnish to its stockholders as soon as practicable after the
end of each fiscal year an annual report (including a balance sheet and statements of income, stockholders&rsquo; equity and cash flow
of the Company and its consolidated Subsidiaries, if any, certified by independent public accountants) and, as soon as practicable after
the end of each of the first three quarters of each fiscal year (beginning with the fiscal quarter ending after the effective date of
the Registration Statement), consolidated summary financial information of the Company and its Subsidiaries, if any, for such quarter
in reasonable detail.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company will make generally available to holders of its securities as soon as may be practicable, but in no event later than the Availability
Date (as defined below), an earning statement (which need not be audited but shall be in reasonable detail) covering a period of 12&nbsp;months
commencing after the Effective Date that will satisfy the provisions of Section&nbsp;11(a)&nbsp;of the Act (including Rule&nbsp;158 of
the Rules&nbsp;and Regulations). For the purpose of the preceding sentence, &ldquo;Availability Date&rdquo; means the 45th day after
the end of the fourth fiscal quarter following the fiscal quarter that includes such Effective Date, except that if such fourth fiscal
quarter is the last quarter of the Company&rsquo;s fiscal year, &ldquo;Availability Date&rdquo; means the 90th day after the end of such
fourth fiscal quarter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Whether
or not the transactions contemplated by this Agreement are consummated or this Agreement is terminated, the Company will pay or reimburse
if paid by the Underwriters, in such proportions as they may agree among themselves, all costs and expenses incident to the performance
of the obligations of the Company under this Agreement and in connection with the transactions contemplated hereby, including but not
limited to costs and expenses of or relating to (i)&nbsp;the preparation, printing and filing of the Registration Statement and exhibits
to it, each preliminary prospectus, the Base Prospectus, the Prospectus Supplement, the Pricing Prospectus, the Prospectus, any Issuer
Free Writing Prospectus, and any amendment or supplement to any of the foregoing, (ii)&nbsp;the preparation and delivery of certificates
representing the Shares, (iii)&nbsp;furnishing (including costs of shipping and mailing) such copies of the Registration Statement, any
preliminary prospectus, the Base Prospectus, the Prospectus Supplement, the Prospectus, and any Issuer Free Writing Prospectus, and all
amendments and supplements thereto, as may be requested for use in connection with the offering and sale of the Shares by the Underwriters
or by dealers to whom Shares may be sold, (iv)&nbsp;any filings required to be made in connection with clearance of the offering of the
Shares with FINRA (including the fees, disbursements and other charges of counsel for the Underwriters in connection therewith), (v)&nbsp;the
registration or qualification of the Shares for offer and sale under the state or foreign securities or Blue Sky laws of such jurisdictions
designated pursuant to Section&nbsp;5(f)&nbsp;and the preparation, printing and distribution of any Blue Sky memoranda (including the
fees, disbursements and other charges of counsel to the Underwriters in connection therewith), (vi)&nbsp;fees, disbursements and other
charges of counsel to the Company and of the Accountants, (vii)&nbsp;the transfer agent for the Shares, (viii)&nbsp;&ldquo;road show&rdquo;
presentations to prospective purchasers of the Shares (including any travel expenses of the Company&rsquo;s officers, directors and employees
in connection with attending or hosting meetings), and (ix)&nbsp;all other costs and expenses of the Underwriters incident to the performance
of their obligations hereunder not otherwise specifically provided for herein, including the fees, disbursements and other charges of
counsel to the Underwriters (in addition to those set forth in clauses (iv)&nbsp;and (v)); provided, however, that in no event under
this clause (ix)&nbsp;shall the Company be required to pay or reimburse if paid by the Underwriters any costs and expenses in excess
of $10,000 in the aggregate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company and the Selling Stockholders will not at any time, directly or indirectly, take any action designed or that might reasonably
be expected to cause or result in, or that will constitute, stabilization of the price of the shares of Common Stock to facilitate the
sale or resale of any of the Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">During
the period beginning from the date hereof and continuing to and including the date that is 90&nbsp;days after the date of the Prospectus,
without the prior written consent of the Representative, the Company will not (1)&nbsp;offer, sell, contract to sell, pledge, grant options,
warrants or rights to purchase, or otherwise dispose of any equity securities of the Company or any other securities convertible into
or exchangeable for its Common Stock or other equity security (other than pursuant to employee stock option plans disclosed in the Prospectus
or pursuant to the conversion of convertible securities or the exercise of warrants in each case outstanding on the date of this Agreement)
or (2)&nbsp;enter into any swap or other derivatives transaction that transfers to another, in whole or in part, any of the economic
benefits or risks of ownership of shares of Common Stock, whether any such transaction described in clause (1)&nbsp;or (2)&nbsp;above
is to be settled by delivery of Common Stock or other securities, in cash or otherwise. Notwithstanding the foregoing, the Company shall
be permitted to (i)&nbsp;issue shares of Common Stock or options to purchase Common Stock or other equity awards, or issue shares of
Common Stock upon exercise of options or in connection with other equity awards, pursuant to any compensatory equity plan, stock bonus
or other stock plan or arrangement described in the Registration Statement, any preliminary prospectus, the Base Prospectus, the Prospectus
Supplement, the Prospectus, (ii)&nbsp;file a registration statement on Form&nbsp;S-8 with respect to any securities issued or issuable
pursuant to any stock option, stock bonus or other stock plan or arrangement, and (iii)&nbsp;issue equity securities in connection with
bona fide mergers or acquisitions, joint ventures, commercial relationships or other strategic transactions (whether by means of merger,
stock purchase, asset purchase or otherwise, and including the filing of a registration statement on Form&nbsp;S-4 or other appropriate
form with respect thereto), provided, that the aggregate number of shares of Common Stock convertible securities into shares of Common
Stock that the Company may sell or issue or agree to sell or issue pursuant to this clause (iii)&nbsp;shall not exceed 5% of the total
number of shares of the Company&rsquo;s Common Stock issued and outstanding immediately following the completion of the transactions
contemplated by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">During
the period of 90 days after the date of the Prospectus, the Company will not, without the prior written consent of the Representative,
grant options to purchase shares of Common Stock at a price less than the public offering price. During the period of 90 days after the
date of the Prospectus, the Company will not file with the Commission or cause to become effective any registration statement relating
to any securities of the Company without the prior written consent of the Representative (except a Form&nbsp;S-8 as noted above).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Selling Stockholders will, and the Company will cause each of its executive officers, directors and certain stockholders designated by
the Representative, to enter into lock-up agreements with the Representative to the effect that they will not, without the prior written
consent of the Representative, sell, contract to sell or otherwise dispose of any shares of Common Stock or rights to acquire such shares
according to the terms set forth in Schedule&nbsp;IV hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><I>Further
Agreements.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company represents and agrees that, without the prior written consent of Needham&nbsp;&amp; Company, LLC, and each Underwriter represents
and agrees that, without the prior written consent of the Company and Needham&nbsp;&amp; Company, LLC, it has not made and will not make
any offer relating to the Shares that would constitute a &ldquo;free writing prospectus&rdquo; as defined in Rule&nbsp;405 of the Rules&nbsp;and
Regulations. Any such free writing prospectus the use of which has been consented to by the Company and Needham&nbsp;&amp; Company, LLC
is listed on Schedule III and herein called a &ldquo;Permitted Free Writing Prospectus.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company agrees that it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing
Prospectus and that it has complied and will comply, as the case may be, with the requirements of Rules&nbsp;164 and 433 of the Rules&nbsp;and
Regulations applicable to any Permitted Free Writing Prospectus, including timely Commission filing where required, record keeping and
legending.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><I>Conditions
of the Obligations of the Underwriters</I> The obligations of each Underwriter hereunder are subject to the following
conditions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">All
filings required by Rule&nbsp;424 and Rule&nbsp;430A of the Rules&nbsp;and Regulations shall have been made. If the Company has elected
to rely upon Rule&nbsp;462(b), the registration statement filed under Rule&nbsp;462(b)&nbsp;shall have become effective by 10:00 p.m.,
Washington, D.C. time, on the date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">(i)&nbsp;No
stop order suspending the effectiveness of the Registration Statement or preventing or suspending the use of the Base Prospectus, any
preliminary prospectus, the Prospectus Supplement, the Prospectus or any Issuer Free Writing Prospectus shall have been issued and no
proceedings for that purpose shall be pending or threatened by the Commission, (ii)&nbsp;no order suspending the effectiveness of the
Registration Statement or the qualification or registration of the Shares under the securities or Blue Sky laws of any jurisdiction shall
be in effect and no proceeding for such purpose shall be pending before or threatened or contemplated by the Commission or the authorities
of any such jurisdiction, (iii)&nbsp;any request for additional information on the part of the staff of the Commission or any such authorities
shall have been complied with to the satisfaction of the staff of the Commission or such authorities, and (iv)&nbsp;after the date hereof
no amendment or supplement to the Registration Statement, the Prospectus or the Pricing Prospectus shall have been filed unless a copy
thereof was first submitted to the Representative and the Representative does not object thereto in good faith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Since
the respective dates as of which information is given in the Registration Statement and the Pricing Prospectus, (i)&nbsp;there shall
not have been a material adverse change in the general affairs, business, business prospects, properties, management, condition (financial
or otherwise) or results of operations of the Company or any of its Subsidiaries, whether or not arising from transactions in the ordinary
course of business, in each case other than as described in or contemplated by the Registration Statement and the Pricing Prospectus,
and (ii)&nbsp; neither the Company nor any of its Subsidiaries shall have sustained any material loss or interference with its business
or properties from fire, explosion, flood or other casualty, whether or not covered by insurance, or from any labor dispute or any court
or legislative or other governmental action, order or decree, which is not described in the Registration Statement and the Pricing Prospectus,
if in the judgment of the Representative any such development makes it impracticable or inadvisable to consummate the sale and delivery
of the Shares by the Underwriters at the public offering price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Since
the respective dates as of which information is given in the Registration Statement and the Pricing Prospectus, there shall have been
no litigation or other proceeding instituted against the Company, any of its Subsidiaries, or any of its or their officers or directors
in their capacities as such, before or by any federal, state or local court, commission, regulatory body, administrative agency or other
governmental body, domestic or foreign, in which litigation or proceeding an unfavorable ruling, decision or finding would, in the judgment
of the Representative, have a Material Adverse Effect or if, in the judgment of the Representative, any such development makes it impracticable
or inadvisable to consummate the sale and delivery of the Shares by the Underwriters at the public offering price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Each
of the representations and warranties of the Company and the Selling Stockholders contained herein shall be true and correct in all respects
(in the case of any representation and warranty containing a materiality or Material Adverse Effect qualification) or in all material
respects (in the case of any other representation and warranty) at the Closing Date and, with respect to the Option Shares, at the applicable
Option Closing Date, and all covenants and agreements contained herein to be performed on the part of the Company or the Selling Stockholders
and all conditions contained herein to be fulfilled or complied with by the Company or the Selling Stockholders at or prior to the Closing
Date and, with respect to the Option Shares, at or prior to the applicable Option Closing Date, shall have been duly performed, fulfilled
or complied with.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Representative shall have received an opinion and negative assurance letter, each dated the Closing Date and, with respect to the Option
Shares, the applicable Option Closing Date, from Faegre Drinker Biddle&nbsp;&amp; Reath LLP, counsel to the Company and the Selling Stockholders,
in form and substance previously agreed to between Faegre Drinker Biddle&nbsp;&amp; Reath LLP and DLA Piper LLP (US), counsel to the
Underwriters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Representative shall have received an opinion and negative assurance letter, each dated the Closing Date or the applicable Option Closing
Date, as the case may be, from DLA Piper LLP (US), counsel to the Underwriters, with respect to the Registration Statement, the Prospectus
and this Agreement, which opinion and negative assurance letter shall be satisfactory in all respects to the Representative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Concurrently
with the execution and delivery of this Agreement, the Accountants shall have furnished to the Representative a letter, dated the date
of its delivery, addressed to the Representative and in form and substance satisfactory to the Representative, confirming that they are
independent accountants with respect to the Company and its Subsidiaries as required by the Act and the Exchange Act and the Rules&nbsp;and
Regulations and with respect to certain financial and other statistical and numerical information contained or incorporated by reference
in the Registration Statement, the Prospectus and the General Disclosure Package. At the Closing Date and, as to the Option Shares, the
applicable Option Closing Date, the Accountants shall have furnished to the Representative a letter, dated the date of its delivery,
which shall confirm, on the basis of a review in accordance with the procedures set forth in the letter from the Accountants, that nothing
has come to their attention during the period from the date of the letter referred to in the prior sentence to a date (specified in the
letter) not more than three days prior to the Closing Date or the applicable Option Closing Date, as the case may be, which would require
any change in their letter dated the date hereof if it were required to be dated and delivered at the Closing Date or the applicable
Option Closing Date, as the case may be.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">At
the Closing Date and, as to the Option Shares, the applicable Option Closing Date, there shall be furnished to the Representative a certificate,
dated the date of its delivery, signed by each of the Chief Executive Officer and the Chief Financial Officer of the Company, in their
capacities as such, in form and substance satisfactory to the Representative, to the effect that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Each
signer of such certificate has carefully examined the Registration Statement, the Prospectus and the General Disclosure Package (including
any documents filed under the Exchange Act and deemed to be incorporated by reference into the Pricing Prospectus and the Prospectus)
and (A)&nbsp;as of the date of such certificate, such documents are true and correct in all material respects and do not omit to state
a material fact required to be stated therein or necessary in order to make the statements therein not untrue or misleading and (B)&nbsp;in
the case of the certificate delivered at the Closing Date and the applicable Option Closing Date, since the Effective Date no event has
occurred as a result of which it is necessary to amend or supplement the Prospectus in order to make the statements therein not untrue
or misleading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Each
of the representations and warranties of the Company contained in this Agreement were, when originally made, and are, at the time such
certificate is delivered, true and correct in all respects (in the case of any representation and warranty containing a materiality or
Material Adverse Effect qualification) or in all material respects (in the case of any other representation and warranty).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Each
of the covenants required to be performed by the Company herein on or prior to the date of such certificate has been duly, timely and
fully performed and each condition herein required to be satisfied or fulfilled on or prior to the date of such certificate has been
duly, timely and fully satisfied or fulfilled.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">At
the Closing Date and, as to the Option Shares, the applicable Option Closing Date, there shall be furnished to the Representative a certificate,
dated the date of its delivery, signed by the Selling Stockholders, in form and substance satisfactory to the Representative, to the
effect that the representations and warranties of the Selling Stockholders contained herein are true and correct in all material respects
on and as of the date of such certificate as if made on and as of the date of such certificate, and each of the covenants and conditions
required herein to be performed or complied with by the Selling Stockholders on or prior to the date of such certificate has been duly,
timely and fully performed or complied with.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">On
or prior to the Closing Date, the Representative shall have received the executed agreements referred to in Section&nbsp;5(m).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Shares shall be qualified for sale in such jurisdictions as the Representative may reasonably request and each such qualification shall
be in effect and not subject to any stop order or other proceeding on the Closing Date or the applicable Option Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company shall have furnished to the Representative such certificates (including a Secretary&rsquo;s Certificate and any good standing
certificates), in addition to those specifically mentioned herein, as the Representative may have reasonably requested as to the accuracy
and completeness at the Closing Date and the applicable Option Closing Date of any statement in the Registration Statement, the Prospectus
or the General Disclosure Package, as to the accuracy at the Closing Date and the applicable Option Closing Date of the representations
and warranties of the Company herein, as to the performance by the Company of its obligations hereunder, or as to the fulfillment of
the conditions concurrent and precedent to the obligations hereunder of the Representative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><I>Indemnification.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company will indemnify and hold harmless each Underwriter, the partners, members, directors, officers, employees, agents and affiliates
of each Underwriter and each person, if any, who controls each Underwriter within the meaning of Section&nbsp;15 of the Act or Section&nbsp;20
of the Exchange Act, from and against any and all losses, claims, liabilities, expenses and damages (including any and all investigative,
legal and other expenses reasonably incurred in connection with, and any amount paid in settlement of, any action, suit or proceeding
or any claim asserted), to which they, or any of them, may become subject under the Act, the Exchange Act or other federal or state statutory
law or regulation, at common law or otherwise, insofar as such losses, claims, liabilities, expenses or damages arise out of or are based
on any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement, any preliminary prospectus,
the Base Prospectus, the Pricing Prospectus, the Prospectus or any amendment or supplement thereto or any Issuer Free Writing Prospectus
or any &ldquo;issuer information&rdquo; filed or required to be filed pursuant to Rule&nbsp;433(d)&nbsp;of the Rules&nbsp;and Regulations,
or the omission or alleged omission to state in such document a material fact required to be stated in it or necessary to make the statements
in it not misleading in the light of the circumstances in which they were made, or arise out of or are based in whole or in part on any
inaccuracy in the representations and warranties of the Company contained herein or any failure of the Company to perform its obligations
hereunder or under law in connection with the transactions contemplated hereby; <I>provided</I>, <I>however</I>, that the Company will
not be liable to the extent that such loss, claim, liability, expense or damage arises from the sale of the Shares in the public offering
to any person by an Underwriter and is based on an untrue statement or omission or alleged untrue statement or omission made in reliance
on and in conformity with information relating to (i)&nbsp;any Underwriter furnished in writing to the Company by the Representative,
on behalf of any Underwriter, expressly for inclusion in the Registration Statement, any preliminary prospectus, the Base Prospectus,
the Pricing Prospectus, the Prospectus or any Issuer Free Writing Prospectus; or (ii)&nbsp;any Selling Stockholder Information. The Company
acknowledges that the statements set forth in the second paragraph under the heading &ldquo;Underwriting&rdquo; and the sections titled,
 &ldquo;Discretionary Accounts,&rdquo; &ldquo;Stabilization,&rdquo; &ldquo;Electronic Offer, Sale and Distribution of Shares,&rdquo; and
 &ldquo;Other Relationships&rdquo; in the Pricing Prospectus and the Prospectus constitute the only information relating to any Underwriter
furnished in writing to the Company by the Representative on behalf of the Underwriters expressly for inclusion in the Registration Statement,
any preliminary prospectus, the Base Prospectus, the Pricing Prospectus, the Prospectus or any Issuer Free Writing Prospectus. This indemnity
agreement will be in addition to any liability that the Company might otherwise have.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Each
of the Selling Stockholders will severally and not jointly, indemnify and hold harmless each Underwriter, the partners, members, directors,
officers, employees, agents and affiliates of each Underwriter and each person, if any, who controls each Underwriter within the meaning
of Section&nbsp;15 of the Act or Section&nbsp;20 of the Exchange Act, from and against any and all losses, claims, liabilities, expenses
and damages (including any and all investigative, legal and other expenses reasonably incurred in connection with, and any amount paid
in settlement of, any action, suit or proceeding or any claim asserted), to which they, or any of them, may become subject under the
Act, the Exchange Act or other federal or state statutory law or regulation, at common law or otherwise, insofar as such losses, claims,
liabilities, expenses or damages arise out of or are based (i)&nbsp;on any untrue statement or alleged untrue statement of a material
fact contained in the Registration Statement, any preliminary prospectus, the Base Prospectus, the Pricing Prospectus, the Prospectus
or any amendment or supplement thereto or any Issuer Free Writing Prospectus or any &ldquo;issuer information&rdquo; filed or required
to be filed pursuant to Rule&nbsp;433(d)&nbsp;of the Rules&nbsp;and Regulations, or the omission or alleged omission to state in such
document a material fact required to be stated in it or necessary to make the statements in it not misleading in the light of the circumstances
in which they were made, in each case solely insofar as such losses, claims, liabilities, expenses or damages which arise out of or are
based on any untrue statement or omission or alleged untrue statement or omission of a material fact made in reliance upon and in conformity
with such Selling Stockholder&rsquo;s Selling Stockholder Information or (ii)&nbsp;in whole or in part on any inaccuracy in the representations
and warranties of the Selling Stockholders contained herein or any failure of the Selling Stockholders to perform their obligations hereunder
or under law in connection with the transactions contemplated hereby; provided, however, that the liability under this subsection and
under Section&nbsp;4 hereof shall be limited in each case to any amount equal to the aggregate net proceeds after underwriting commissions
and discounts, but before expenses, to such Selling Stockholder form the sale of Shares sold by such Selling Stockholder hereunder. This
indemnity agreement will be in addition to any liability that each Underwriter might otherwise have.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Each
Underwriter, severally and not jointly, will indemnify and hold harmless the Company, each director of the Company, each officer of the
Company who signs the Registration Statement, each person, if any, who controls the Company within the meaning of Section&nbsp;15 of
the Act or Section&nbsp;20 of the Exchange Act, and each Selling Stockholder to the same extent as the foregoing indemnity from the Company
and each Selling Stockholder to each Underwriter, as set forth in Section&nbsp;8(a)&nbsp;and (b), but only insofar as losses, claims,
liabilities, expenses or damages arise out of or are based on any untrue statement or omission or alleged untrue statement or omission
made in reliance on and in conformity with information relating to any Underwriter furnished in writing to the Company by the Representative,
on behalf of such Underwriter, expressly for inclusion in the Registration Statement, any preliminary prospectus, the Base Prospectus,
the Pricing Prospectus, the Prospectus or any Issuer Free Writing Prospectus. The Company and the Selling Stockholders acknowledge that
the statements set forth in the second paragraph under the heading &ldquo;Underwriting&rdquo; and the sections titled, &ldquo;Discretionary
Accounts,&rdquo; &ldquo;Stabilization,&rdquo; &ldquo;Electronic Offer, Sale and Distribution of Shares,&rdquo; and &ldquo;Other Relationships&rdquo;
in the Pricing Prospectus and the Prospectus constitute the only information relating to any Underwriter furnished in writing to the
Company by the Representative on behalf of the Underwriters expressly for inclusion in the Registration Statement, any preliminary prospectus,
the Base Prospectus, the Pricing Prospectus, the Prospectus or any Issuer Free Writing Prospectus. This indemnity will be in addition
to any liability that each Underwriter might otherwise have.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Any
party that proposes to assert the right to be indemnified under this Section&nbsp;8 shall, promptly after receipt of notice of commencement
of any action against such party in respect of which a claim is to be made against an indemnifying party or parties under this Section&nbsp;8,
notify each such indemnifying party in writing of the commencement of such action, enclosing with such notice a copy of all papers served,
but the omission so to notify such indemnifying party will not relieve it from any liability that it may have to any indemnified party
under the foregoing provisions of this Section&nbsp;8 unless, and only to the extent that, such omission results in the loss of substantive
rights or defenses by the indemnifying party. If any such action is brought against any indemnified party and it notifies the indemnifying
party of its commencement, the indemnifying party will be entitled to participate in and, to the extent that it elects by delivering
written notice to the indemnified party promptly after receiving notice of the commencement of the action from the indemnified party,
jointly with any other indemnifying party similarly notified, to assume the defense of the action, with counsel reasonably satisfactory
to the indemnified party. After notice from the indemnifying party to the indemnified party of its election to assume the defense, the
indemnifying party will not be liable to the indemnified party for any legal or other expenses except as provided below and except for
the reasonable costs of investigation incurred by the indemnified party in connection with the defense. The indemnified party will have
the right to employ its own counsel in any such action, but the fees, expenses and other charges of such counsel will be at the expense
of such indemnified party unless (i)&nbsp;the employment of counsel by the indemnified party has been authorized in writing by the indemnifying
party, (ii)&nbsp;the indemnified party has reasonably concluded (based on advice of counsel) that there may be legal defenses available
to it or other indemnified parties that are different from or in addition to those available to the indemnifying party, (iii)&nbsp;a
conflict or potential conflict exists (based on advice of counsel to the indemnified party) between the indemnified party and the indemnifying
party (in which case the indemnifying party will not have the right to direct the defense of such action on behalf of the indemnified
party), or (iv)&nbsp;the indemnifying party has not in fact employed counsel reasonably satisfactory to the indemnified party to assume
the defense of such action within a reasonable time after receiving notice of the commencement of the action, in each of which cases
the reasonable fees, disbursements and other charges of counsel will be at the expense of the indemnifying party or parties. It is understood
that the indemnifying party or parties shall not, in connection with any proceeding or related proceedings in the same jurisdiction,
be liable for the reasonable fees, disbursements and other charges of more than one separate firm admitted to practice in such jurisdiction
at any one time for all such indemnified party or parties. All such reasonable fees, disbursements and other charges will be reimbursed
by the indemnifying party promptly as they are incurred. No indemnifying party shall, without the prior written consent of the indemnified
party, effect any settlement of any pending or threatened action in respect of which any indemnified party is or could have been a party
and indemnity could have been sought hereunder by such indemnified party unless such settlement (A)&nbsp;includes an unconditional release
of such indemnified party from all liability on any claims that are the subject matter of such action and (B)&nbsp;does not include a
statement as to, or an admission of, fault, culpability or a failure to act by or on behalf of an indemnified party. An indemnifying
party will not be liable for any settlement of any action or claim effected without its written consent (which consent will not be unreasonably
withheld or delayed).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">If
the indemnification provided for in this Section&nbsp;8 is applicable in accordance with its terms but for any reason is held to be unavailable
to or insufficient to hold harmless an indemnified party under paragraphs (a), (b)&nbsp;and (c)&nbsp;of this Section&nbsp;8 in respect
of any losses, claims, liabilities, expenses and damages referred to therein, then each applicable indemnifying party, in lieu of indemnifying
such indemnified party, shall contribute to the amount paid or payable (including any investigative, legal and other expenses reasonably
incurred in connection with, and any amount paid in settlement of, any action, suit or proceeding or any claim asserted, but after deducting
any contribution received by the Company or the Selling Stockholders from persons other than the Underwriters, such as persons who control
the Company within the meaning of the Act, officers of the Company who signed the Registration Statement and directors of the Company,
who also may be liable for contribution) by such indemnified party as a result of such losses, claims, liabilities, expenses and damages
in such proportion as shall be appropriate to reflect the relative benefits received by the Company and the Selling Stockholders, on
the one hand, and the Underwriters, on the other hand. The relative benefits received by the Company and the Selling Stockholders, on
the one hand, and the Underwriters, on the other hand, shall be deemed to be in the same proportion as the total net proceeds from the
offering (before deducting expenses) received by the Company and the Selling Stockholders bear to the total underwriting discounts and
commissions received by the Underwriters, in each case as set forth in the table on the cover page&nbsp;of the Prospectus. If, but only
if, the allocation provided by the foregoing sentence is not permitted by applicable law, the allocation of contribution shall be made
in such proportion as is appropriate to reflect not only the relative benefits referred to in the foregoing sentence but also the relative
fault of the Company and the Selling Stockholders, on the one hand, and the Underwriters, on the other hand, with respect to the statements
or omissions that resulted in such loss, claim, liability, expense or damage, or action in respect thereof, as well as any other relevant
equitable considerations with respect to such offering. Such relative fault shall be determined by reference to whether the untrue or
alleged untrue statement of a material fact or omission or alleged omission to state a material fact relates to information supplied
by the Company, the Selling Stockholders or the Representative on behalf of the Underwriters, the intent of the parties and their relative
knowledge, access to information and opportunity to correct or prevent such statement or omission. The Company, the Selling Stockholders
and the Underwriters agree that it would not be just and equitable if contributions pursuant to this Section&nbsp;8(e)&nbsp;were to be
determined by pro rata allocation (even if the Underwriters were treated as one entity for such purpose) or by any other method of allocation
that does not take into account the equitable considerations referred to herein. The amount paid or payable by an indemnified party as
a result of the loss claim, liability, expense or damage, or action in respect thereof, referred to above in this Section&nbsp;8(e)&nbsp;shall
be deemed to include, for purposes of this Section&nbsp;8(e), any legal or other expenses reasonably incurred by such indemnified party
in connection with investigating or defending any such action or claim. Notwithstanding the provisions of this Section&nbsp;8(e), (i)&nbsp;no
Underwriter shall be required to contribute any amount in excess of the underwriting discounts and commissions received by it, (ii)&nbsp;no
Selling Stockholder shall be required to contribute any amount in excess of such Selling Stockholder&rsquo;s aggregate net proceeds after
deducting underwriters&rsquo; commissions and discounts, but before expenses, to such Selling Stockholder from the sale of Shares sold
by such Selling Stockholder hereunder and (iii)&nbsp;no person found guilty of fraudulent misrepresentation (within the meaning of Section&nbsp;11(f)&nbsp;of
the Act) will be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. The Underwriters&rsquo;
obligations to contribute as provided in this Section&nbsp;8(e)&nbsp;are several in proportion to their respective underwriting obligations
and not joint. For purposes of this Section&nbsp;8(e), any person who controls a party to this Agreement within the meaning of the Act
will have the same rights to contribution as that party, and each officer of the Company who signed the Registration Statement will have
the same rights to contribution as the Company, subject in each case to the provisions hereof. Any party entitled to contribution, promptly
after receipt of notice of commencement of any action against any such party in respect of which a claim for contribution may be made
under this Section&nbsp;8(e), will notify any such party or parties from whom contribution may be sought, but the omission so to notify
will not relieve the party or parties from whom contribution may be sought from any other obligation it or they may have under this Section&nbsp;8(e).
No party will be liable for contribution with respect to any action or claim settled without its written consent (which consent will
not be unreasonably withheld).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
indemnity and contribution agreements contained in this Section&nbsp;8 and the representations and warranties of the Company and the
Selling Stockholders contained in this Agreement shall remain operative and in full force and effect regardless of (i)&nbsp;any investigation
made by or on behalf of the Underwriters, (ii)&nbsp;acceptance of any of the Shares and payment therefor, or (iii)&nbsp;any termination
of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><I>Reimbursement
of Certain Expenses. </I>In addition to its other obligations under Section&nbsp;8(a)&nbsp;of this Agreement, the Company hereby agrees
to reimburse the Underwriters on a quarterly basis for all reasonable legal and other expenses incurred in connection with investigating
or defending any claim, action, investigation, inquiry or other proceeding arising out of or based upon, in whole or in part, any statement
or omission or alleged statement or omission, or any inaccuracy in the representations and warranties of the Company or the Selling Stockholder
contained herein or failure of the Company or the Selling Stockholders to perform its or their respective obligations hereunder or under
law, all as described in Section&nbsp;8(a), notwithstanding the absence of a judicial determination as to the propriety and enforceability
of the obligations under this Section&nbsp;8 and the possibility that such payment might later be held to be improper; provided, however,
that, to the extent any such payment is ultimately held to be improper, the persons receiving such payments shall promptly refund them.10.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><I>Termination.</I>The
obligations of the several Underwriters under this Agreement may be terminated at any time on or prior to the Closing Date (or, with
respect to the Option Shares, on or prior to the applicable Option Closing Date), by notice to the Company and the Selling Stockholders
from the Representative, without liability on the part of any Underwriter to the Company or any Selling Stockholder if, prior to delivery
and payment for the Firm Shares or the Option Shares, as the case may be, in the sole judgment of the Representative, (i)&nbsp;trading
in any of the equity securities of the Company shall have been suspended or limited by the Commission or by the Trading Market, (ii)&nbsp;trading
in securities generally on the Trading Market shall have been suspended or limited or minimum or maximum prices shall have been generally
established on such exchange, or additional material governmental restrictions, not in force on the date of this Agreement, shall have
been imposed upon trading in securities generally by such exchange, by order of the Commission or any court or other governmental authority
or by the Trading Market, (iii)&nbsp;a general banking moratorium shall have been declared by either federal or New York State authorities
or any material disruption of the securities settlement or clearance services in the United States shall have occurred, or (iv)&nbsp;any
material adverse change in the financial or securities markets in the United States or in political, financial or economic conditions
in the United States, any outbreak or material escalation of hostilities involving the United States, a declaration of a national emergency
or war by the United States, or other calamity or crisis, either within or outside the United States, shall have occurred, the effect
of which is such as to make it, in the sole judgment of the Representative, impracticable or inadvisable to proceed with completion of
the public offering or the delivery of and payment for the Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If this Agreement is terminated
pursuant to Section&nbsp;10 hereof, neither the Company nor any Selling Stockholder shall be under any liability to any Underwriter except
as provided in Sections 5(j), 8 and 9 hereof, as applicable; but, if for any other reason the purchase of the Shares by the Underwriters
is not consummated or if for any reason the Company shall be unable to perform its obligations hereunder, the Company will reimburse
the Underwriters for all out-of-pocket expenses (including the fees, disbursements and other charges of counsel to the Underwriters)
incurred by the Underwriters in connection with the offering of the Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><I>Substitution
of Underwriters. </I>If any one or more of the Underwriters shall fail or refuse to purchase any of the Firm Shares that it or they have
agreed to purchase hereunder, and the aggregate number of Firm Shares that such defaulting Underwriter or Underwriters agreed but failed
or refused to purchase is not more than one-tenth of the aggregate number of Firm Shares, the other Underwriters shall be obligated,
severally and not jointly, to purchase the Firm Shares that such defaulting Underwriter or Underwriters agreed but failed or refused
to purchase, in the proportions which the number of Firm Shares that they have respectively agreed to purchase pursuant to Section&nbsp;1
bears to the aggregate number of Firm Shares which all such non-defaulting Underwriters have so agreed to purchase, or in such other
proportions as the Representative may specify; provided that in no event shall the maximum number of Firm Shares that any Underwriter
has become obligated to purchase pursuant to Section&nbsp;1 be increased pursuant to this Section&nbsp;11 by more than one-ninth of such
number of Firm Shares without the prior written consent of such Underwriter. In any such case either the Representative or the Company
shall have the right to postpone the Closing Date, but in no event for longer than seven days, in order that the required changes, if
any, in the Registration Statement and the Prospectus or in any other documents or arrangements may be effected. If any Underwriter or
Underwriters shall fail or refuse to purchase any Firm Shares that it or they agreed to purchase hereunder and the aggregate number of
Firm Shares which such defaulting Underwriter or Underwriters agreed but failed or refused to purchase exceeds one-tenth of the aggregate
number of the Firm Shares and arrangements satisfactory to the Representative and the Company for the purchase of such Firm Shares are
not made within 48&nbsp;hours after such default, this Agreement will terminate without liability on the part of any non-defaulting Underwriter,
the Company or the Selling Stockholders for the purchase or sale of any Shares under this Agreement. Any action taken pursuant to this
Section&nbsp;11 shall not relieve any defaulting Underwriter from liability in respect of any default of such Underwriter under this
Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><I>No
Fiduciary Relationship. </I>Notwithstanding any preexisting relationship, advisory or otherwise, between the parties or any oral representations
or assurances previously or subsequently made by the Underwriters, the Company and each Selling Stockholder acknowledges and agrees that
(i)&nbsp;the purchase and sale of the Shares pursuant to this Agreement (including the determination of the terms of the offering of
the Shares) is an arm&rsquo;s-length commercial transaction between the Company and the Selling Stockholders, on the one hand, and the
several Underwriters, on the other hand, (ii)&nbsp;in connection therewith and with the process leading to such transaction, each Underwriter
is acting solely as a principal and not the agent or fiduciary of the Company or any Selling Stockholder, (iii)&nbsp;no Underwriter has
assumed an advisory or fiduciary responsibility in favor of the Company or any Selling Stockholder with respect to the offering contemplated
hereby or the process leading thereto (irrespective of whether such Underwriter has advised or is currently advising the Company or any
such Selling Stockholder on other matters) or any other obligation to the Company or any Selling Stockholder except the obligations expressly
set forth in this Agreement, (iv)&nbsp;the Underwriters and their respective affiliates may be engaged in a broad range of transactions
that involve interests that differ from those of the Company or any Selling Stockholder and have no obligation to disclose or account
to the Company or any Selling Stockholder for any of such differing interests, and (v)&nbsp;the Company and each Selling Stockholder
has consulted its own legal, tax, accounting and financial advisors to the extent it deemed appropriate.&nbsp; The Company and each Selling
Stockholder hereby agrees that it will not claim that the Underwriters, or any of them, have rendered advisory services of any nature
or respect, or owe a fiduciary or similar duty to the Company or any Selling Stockholder, in connection with such transaction or the
process leading thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><I>Recognition
of the U.S. Special Resolution Regimes</I>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;In
the event that any Underwriter that is a Covered Entity becomes subject to a proceeding under a U.S. Special Resolution Regime, the transfer
from such Underwriter of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same extent
as the transfer would be effective under the U.S. Special Resolution Regime if this Agreement, and any such interest and obligation,
were governed by the laws of the United States or a state of the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">In
the event that any Underwriter that is a Covered Entity or a BHC Act Affiliate of such Underwriter becomes subject to a proceeding under
a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against such Underwriter are permitted to
be exercised to no greater extent than such Default Rights could be exercised under the U.S. Special Resolution Regime if this Agreement
were governed by the laws of the United States or a state of the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">For
purposes of this Section&nbsp;11, a &ldquo;BHC Act Affiliate&rdquo; has the meaning assigned to the term &ldquo;affiliate&rdquo; in,
and shall be interpreted in accordance with, 12 U.S.C. &sect; 1841(k). &ldquo;Covered Entity&rdquo; means any of the following: (i)&nbsp;a
 &ldquo;covered entity&rdquo; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &sect; 252.82(b); (ii)&nbsp;a
 &ldquo;covered bank&rdquo; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &sect; 47.3(b); or (iii)&nbsp;a
 &ldquo;covered FSI&rdquo; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &sect; 382.2(b). &ldquo;Default Right&rdquo;
has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. &sect;&sect; 252.81, 47.2 or 382.1,
as applicable. &ldquo;U.S. Special Resolution Regime&rdquo; means each of (i)&nbsp;the Federal Deposit Insurance Act and the regulations
promulgated thereunder and (ii)&nbsp;Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated
thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><I>Miscellaneous.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Notice
given pursuant to any of the provisions of this Agreement shall be in writing and, unless otherwise specified, shall be mailed or delivered
(a)&nbsp;if to the Company or the Selling Stockholders, at the office of the Company, AudioEye,&nbsp;Inc., 5210 E. Williams Circle, Suite&nbsp;750,
Tucson, AZ 85711, Attention of Kelly Georgevich, with a copy to Faegre Drinker Biddle&nbsp;&amp; Reath LLP, 90 S 7th Street, Unit 2200,
Minneapolis, MN 55402, telecopy number: (612) 766-1600, Attention: Jonathan Zimmerman; or (b)&nbsp;if to the Underwriters, to the Representative
at the offices of Needham&nbsp;&amp; Company, LLC, 250&nbsp;Park Avenue, New York, NY 10177, Attention: Corporate Finance Department,
with a copy to DLA Piper LLP (US), 303 Colorado Street, Suite&nbsp;3000, Austin, TX 78702, telecopy number: (512) 457-7001, Attention:
Drew Valentine, P.C. Any such notice shall be effective only upon receipt. Any notice under Section&nbsp;10 or 11 may be made by telecopier
or telephone, but if so made shall be subsequently confirmed in writing. Any such notice shall be effective only upon receipt. Each such
notice or other communication shall be deemed given (i)&nbsp;when delivered personally or by verifiable facsimile transmission (with
an original to follow) on or before 4:30 p.m., New York City time, on a business day or, if such day is not a business day, on the next
succeeding business day, (ii)&nbsp;on the next business day after timely delivery to a nationally-recognized overnight courier, (iii)&nbsp;on
the business day actually received if deposited in the U.S. mail (certified or registered mail, return receipt requested, postage prepaid)
and (iv)&nbsp;by Electronic Notice as set forth in the following paragraph. For purposes of this Agreement, &ldquo;business day&rdquo;
shall mean any day on which the Exchange and commercial banks in New York City are open for business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">An electronic communication
(&ldquo;Electronic Notice&rdquo;) shall be deemed written notice for purposes of this Section&nbsp;12(a)&nbsp;if sent to the electronic
mail address specified by the receiving party in this Section&nbsp;12(a). Electronic Notice shall be deemed received at the time the
party sending Electronic Notice receives actual acknowledgment of receipt from the person to whom notice is sent, other than automatic
reply. Any party receiving Electronic Notice may request and shall be entitled to receive the notice on paper, in a nonelectronic form
(&ldquo;Nonelectronic Notice&rdquo;), which shall be sent to the requesting party within 10 days of receipt of the written request for
Nonelectronic Notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">This
Agreement has been and is made solely for the benefit of the several Underwriters, the Company, the Selling Stockholders and the persons
referred to in Section&nbsp;8, and their respective successors and permitted assigns, and no other person shall acquire or have any right
under or by virtue of this Agreement. The term &ldquo;successors and assigns&rdquo; as used in this Agreement shall not include a purchaser,
as such purchaser, of Shares. Neither party may assign its rights or obligations under this Agreement without the prior written consent
of the other party; <I>provided</I>, <I>however</I>, that an Underwriter may assign its rights and obligations hereunder to an affiliate
thereof without obtaining the Company&rsquo;s and Selling Stockholders&rsquo; consents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">This
Agreement (including all schedules and exhibits attached hereto) constitutes the entire agreement and supersedes all other prior and
contemporaneous agreements and undertakings, both written and oral, among the parties hereto with regard to the subject matter hereof.
Neither this Agreement nor any term hereof may be amended except pursuant to a written instrument executed by the Company and the Underwriters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">This
Agreement shall be governed by and construed in accordance with the laws of the State of New York applicable to contracts made and to
be performed entirely within such State and without regard to principles of conflicts of laws. Unless stated otherwise, specified times
of day refer to New York City time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">No
implied waiver by a party shall arise in the absence of a waiver in writing signed by such party. No failure or delay in exercising any
right, power, or privilege hereunder shall operate as a waiver thereof, nor shall any single or partial exercise thereof preclude any
other or further exercise thereof or the exercise of any right, power, or privilege hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">This
Agreement may be signed in two or more counterparts with the same effect as if the signatures thereto and hereto were upon the same instrument.
Delivery of an executed Agreement by one party to the other may be made by facsimile or electronic transmission (including any electronic
signature covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act, the Electronic Signatures and Records Act
or other applicable law) and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective
for all purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">In
the event that any one or more of the provisions contained herein, or the application thereof in any circumstance, is held invalid, illegal
or unenforceable as written by a court of competent jurisdiction, then such provision shall be given full force and effect to the fullest
possible extent that it is valid, legal and enforceable, and the remainder of the terms and provisions herein shall be construed as if
such invalid, illegal or unenforceable term or provision was not contained herein, but only to the extent that giving effect to such
provision and the remainder of the terms and provisions hereof shall be in accordance with the intent of the parties as reflected in
this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B>EACH
OF THE COMPANY, THE SELLING STOCKHOLDERS AND THE UNDERWRITERS HEREBY WAIVES ANY RIGHT IT MAY&nbsp;HAVE TO A TRIAL BY JURY IN RESPECT
OF ANY CLAIM BASED UPON, RELATING TO OR ARISING OUT OF THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Each
party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in New York City, Borough of Manhattan,
for the adjudication of any dispute hereunder or in connection with any of the transactions contemplated hereby, and hereby irrevocably
waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of
any such court, that such suit, action or proceeding is brought in an inconvenient forum, or that the venue of such suit, action or proceeding
is improper. Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit,
action or proceeding by mailing a copy (certified or registered mail, return receipt requested) to such party at the address in effect
for notices under Section&nbsp;12(a)&nbsp;of this Agreement and agrees that such service shall constitute good and sufficient notice
of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner
permitted by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B>TIME
SHALL BE OF THE ESSENCE OF THIS AGREEMENT. EXCEPT AS OTHERWISE SET FORTH HEREIN, SPECIFIED TIMES OF DAY REFER TO NEW YORK CITY TIME.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Section&nbsp;headings herein are for convenience only and shall not affect the construction hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Please confirm that the foregoing
correctly sets forth the agreement among the Company, the Selling Stockholders and the several Underwriters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD COLSPAN="3" STYLE="text-align: justify">Very truly yours,</TD>
</TR><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD COLSPAN="3" STYLE="text-align: justify">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD COLSPAN="3" STYLE="text-align: justify"><FONT STYLE="font-variant: small-caps"><B>AudioEye,&nbsp;Inc.</B></FONT></TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD COLSPAN="3" STYLE="text-align: justify">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
                                        <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: justify"><FONT STYLE="font-size: 10pt">/s/
                                        Kelly Georgevich</FONT></TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 50%">&nbsp;</TD><TD STYLE="text-align: justify; width: 3%">&nbsp;</TD>
                                        <TD STYLE="text-align: justify; width: 5%">Name:</TD>
                                        <TD STYLE="text-align: justify; width: 42%">Kelly Georgevich</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD>
                                        <TD STYLE="text-align: justify">Title:</TD>
                                        <TD STYLE="text-align: justify">Chief Financial Officer</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD COLSPAN="3" STYLE="text-align: justify">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD COLSPAN="3" STYLE="text-align: justify"><FONT STYLE="font-variant: small-caps"><B>Selling
                                        Stockholders</B></FONT></TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD COLSPAN="3" STYLE="text-align: justify">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD COLSPAN="3" STYLE="text-align: justify"><FONT STYLE="font-variant: small-caps"><B>Sero Capital,
                                        LLC</B></FONT></TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD COLSPAN="3" STYLE="text-align: justify">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
                                        <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: justify"><FONT STYLE="font-size: 10pt">s/s
                                        David Moradi</FONT></TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD>
                                        <TD STYLE="text-align: justify">Name:</TD>
                                        <TD STYLE="text-align: justify">David Moradi</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD>
                                        <TD STYLE="text-align: justify">Its:</TD>
                                        <TD STYLE="text-align: justify">Sole Member</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD COLSPAN="3" STYLE="text-align: justify">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD COLSPAN="3" STYLE="text-align: justify"><FONT STYLE="font-variant: small-caps"><B>CSB IV
                                        US Holdings LLC</B></FONT></TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD COLSPAN="3" STYLE="text-align: justify">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
                                        <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
                                        Carr Bettis</FONT></TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD>
                                        <TD STYLE="text-align: justify">Name:</TD>
                                        <TD STYLE="text-align: justify">Carr Bettis</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD>
                                        <TD STYLE="text-align: justify">Its:</TD>
                                        <TD STYLE="text-align: justify">Manager</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD COLSPAN="3" STYLE="text-align: justify">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD COLSPAN="3" STYLE="text-align: justify"><FONT STYLE="font-variant: small-caps"><B>Turnmark
                                        Partners, L.P.</B></FONT></TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD COLSPAN="3" STYLE="text-align: justify">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">By:</TD>
                                        <TD COLSPAN="2" STYLE="text-align: justify">Turnmark Capital LLC, its General Partner</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD COLSPAN="3" STYLE="text-align: justify">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
                                        <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: justify">&#8239;<FONT STYLE="font-size: 10pt">/s/
                                        Jamil Tahir</FONT></TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD>
                                        <TD STYLE="text-align: justify">Name:</TD>
                                        <TD STYLE="text-align: justify">Jamil Tahir</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD>
                                        <TD STYLE="text-align: justify">Title:</TD>
                                        <TD STYLE="text-align: justify">Managing Member</TD></TR>
     </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Confirmed as of the date first</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">above mentioned:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-variant: small-caps"><B>Needham&nbsp;&amp;
Company, LLC</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Acting on behalf of itself</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">and as the Representative
of</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">the other several Underwriters</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">named in Schedule&nbsp;I
hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD COLSPAN="3" STYLE="text-align: left"><FONT STYLE="font-variant: small-caps"><B>Needham&nbsp;&amp; Company, LLC</B></FONT></TD><TD STYLE="text-align: justify">&nbsp;</TD>
</TR><TR STYLE="vertical-align: top; text-align: justify">
<TD COLSPAN="3" STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
<TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;/s/ Matt Castrovince</FONT></TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 3%">&nbsp;</TD>
<TD STYLE="text-align: left; width: 5%">Name:</TD>
<TD STYLE="text-align: left; width: 42%">Matt Castrovince</TD><TD STYLE="text-align: justify; width: 50%">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD>
<TD STYLE="text-align: left">Title:</TD>
<TD STYLE="text-align: left">Managing Director</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
     </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>SCHEDULE I</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNDERWRITERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 50%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">Underwriters</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Number<BR>
    of Firm<BR> Shares to<BR>
    be<BR>
    Purchased</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 84%; text-align: left; text-indent: -12pt; padding-left: 12pt">Needham&nbsp;&amp;
    Company, LLC</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 4%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">937,500</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -12pt; padding-left: 12pt">Roth Capital Partners,
    LLC</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">312,500</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: -12pt; padding-left: 0.5in">Total</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,250,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEDULE II</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SELLING STOCKHOLDERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 60%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Total<BR>
    Number<BR>
    of<BR> Firm<BR>
    Shares<BR> to be Sold</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Total<BR>
    Number<BR>
    of<BR> Option<BR>
    Shares<BR> to be<BR>
    Sold</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 74%; text-align: left; text-indent: -12pt; padding-left: 12pt">Sero Capital,
    LLC</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">900,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">135,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -12pt; padding-left: 12pt">CSB IV US Holdings
    LLC</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">225,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">33,750</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -12pt; padding-left: 12pt">Turnmark Partners,
    L.P.</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">125,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">18,750</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: -12pt; padding-left: 0.5in">Totals</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,250,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">187,500</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 34; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>tm2430240d1_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AudioEye Announces Launch of Secondary Offering
of Common Stock by Selling Stockholders</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>TUCSON,
Ariz, December&nbsp;4, 2024</B></FONT> &ndash; AudioEye,&nbsp;Inc. (&quot;AudioEye&quot; or the &quot;Company&quot;) (Nasdaq: AEYE), the
industry-leading digital accessibility company, today announced the launch of an underwritten secondary offering of shares of its common
stock to be sold by certain selling stockholders. The selling stockholders also expect to grant to the underwriters an option, exercisable
for 30 days, to purchase additional shares of the Company's common stock from the selling stockholders at the public offering price, less
underwriting discounts and commissions. <FONT STYLE="background-color: white">The offering is subject to market and other conditions,
and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">Needham&nbsp;&amp;
Company will act as Sole Book-Runner, and Roth Capital Partners will act as Lead Manager for the offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">The selling
stockholders will receive all of the net proceeds from the proposed offering. The Company will not sell any shares of its common stock
in the proposed offering and will not receive any proceeds from the sale of shares of the Company&rsquo;s stock in the offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">This
offering is being</FONT> made pursuant to a shelf registration statement on Form&nbsp;S-3 (File No.&nbsp;333-276937) filed with the Securities
and Exchange Commission (the &ldquo;SEC&rdquo;) and declared effective on February&nbsp;13, 2024. <FONT STYLE="background-color: white">The
offering of the shares of common stock will be made by means of a prospectus, including a prospectus supplement, forming a part of the
registration statement. A preliminary prospectus supplement and the accompanying prospectuses relating to and describing the terms of
the offering will be filed with the SEC, and will be available on the SEC&rsquo;s website at http://www.sec.gov or when available, may
be obtained by contacting: Needham&nbsp;&amp; Company, LLC, 250 Park Avenue, 10th Floor, New York, NY 10177, Attn: Prospectus Department,
by telephone at (800) 903-3268 or by e-mail at prospectus@needhamco.com, with a copy to Roth Capital Partners, LLC, 888 San Clemente,
Suite&nbsp;400, Newport Beach, CA 92660, Attn:&nbsp; Equity Capital Markets, by telephone at (800) 678-9147 or by e-mail at rothecm@roth.com.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This press release shall not constitute an offer
to sell or a solicitation of an offer to buy nor shall there be any sale of these securities in any state or other jurisdiction in which
such offer, solicitation, or sale would be unlawful prior to the registration or qualification under the securities laws of any such state
or other jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>About AudioEye</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">AudioEye exists to ensure the digital future we
build is inclusive. By combining the latest AI automation technology with guidance from certified experts and direct input from the disability
community, AudioEye helps ensure businesses of all sizes &mdash; including over 126,000 customers like Samsung, Calvin Klein, and Samsonite
 &mdash; are accessible and usable. Holding 23 US patents, AudioEye helps companies solve every aspect of digital accessibility with flexible
approaches that best meet their needs. The comprehensive solution includes 24/7 accessibility monitoring, automated accessibility fixes,
expert testing, developer tools, and industry-leading legal protection.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Statements contained in this press release regarding
matters that are not historical facts are &ldquo;forward-looking statements&rdquo; within the meaning of the Private Securities Litigation
Reform Act of 1995, as amended. Words such as &ldquo;anticipates,&rdquo; &ldquo;believes,&rdquo; &ldquo;expects,&rdquo; &ldquo;intends,&rdquo;
 &ldquo;plans,&rdquo; &ldquo;potential,&rdquo; &ldquo;projects,&rdquo; &ldquo;would,&rdquo; and &ldquo;future,&rdquo; or similar expressions,
are intended to identify forward-looking statements. These forward-looking statements reflect AudioEye&rsquo;s current beliefs and expectations
and involve risks and uncertainties that could cause actual results to differ significantly from those expressed or implied by such forward-looking
statements. Forward-looking statements contained in this press release include, but are not limited to statements relating to the offering,
its size and expected closing date. Each of these forward-looking statements involves substantial risks and uncertainties that could cause
actual results to differ significantly from those expressed or implied by such forward-looking statements, including, without limitation,
risks and uncertainties related to: the uncertain market acceptance of our existing and future products; our need for, and the availability
of, additional capital in the future to fund our operations and the development of new products; the success, timing and financial consequences
of new strategic relationships or licensing agreements we may enter into; rapid changes in Internet-based applications that may affect
the utility and commercial viability of our products; the timing and magnitude of expenditures we may incur in connection with our ongoing
product development activities; judicial applications of accessibility laws to the internet; the level of competition from our existing
competitors and from new competitors in our marketplace; and the regulatory environment for our products and services. We undertake no
obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except
as required by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Investor Contact</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Tom Colton<BR>
Gateway Group,&nbsp;Inc.<BR>
</FONT><U>AEYE@gateway-grp.com</U><BR>
949-574-3860</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>4
<FILENAME>tm2430240d1_ex99-2.htm
<DESCRIPTION>EXHIBIT 99.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><B>&nbsp;Exhibit 99.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><B>AudioEye
Announces Pricing of Secondary Offering of Common Stock by Selling </B></FONT><B><FONT STYLE="background-color: white">Stockholders</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><B>TUCSON,
Ariz, December&nbsp;5, 2024</B></FONT> <FONT STYLE="background-color: white">&ndash; AudioEye,&nbsp;Inc. (&quot;AudioEye&quot; or the
 &quot;Company&quot;) (Nasdaq: AEYE), the industry-leading digital accessibility company, today</FONT> announced the pricing of the previously
announced underwritten secondary offering of up to 1,250,000 shares of its common stock to be sold by certain selling stockholders at
a price to the public of $24.00 per share, before underwriting discounts and commissions. The offering is expected to close on December&nbsp;6,
2024, subject to customary closing conditions. The underwriters have a 30-day option to purchase up to an additional 187,500 shares of
the Company's common stock from the selling stockholders at the public offering price, less underwriting discounts and commissions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: #FEFEFE">Needham&nbsp;&amp;
Company is acting as Sole Book-Runner, and Roth Capital Partners is acting as Lead Manager for the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: #FEFEFE">The selling stockholders
will receive all of the net proceeds from the proposed offering. The Company will not sell any shares of its common stock in the proposed
offering and will not receive any proceeds from the sale of shares of the Company&rsquo;s stock in the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: #FEFEFE">This offering is being
made pursuant to a shelf registration statement on Form&nbsp;S-3 (File No.&nbsp;333-276937) filed with the Securities and Exchange Commission
(the &ldquo;SEC&rdquo;) and declared effective on February&nbsp;13, 2024. The offering of the shares of common stock is being made by
means of a prospectus, including a prospectus supplement, forming a part of the registration statement. A preliminary prospectus supplement
and the accompanying prospectus relating to and describing the terms of the offering has been filed with the SEC and is available on the
SEC&rsquo;s website at&nbsp;<U>http://www.sec.gov</U>. A final prospectus supplement and the accompanying prospectus relating to the offering
will be filed with the SEC. Copies of the prospectus supplement and the accompanying prospectus relating to this offering can be obtained,
when available, by contacting: Needham&nbsp;&amp; Company, LLC, 250 Park Avenue, 10th Floor, New York, NY 10177, Attn: Prospectus Department,
by telephone at (800) 903-3268 or by e-mail at prospectus@needhamco.com, with a copy to Roth Capital Partners, LLC, 888 San Clemente,
Suite&nbsp;400, Newport Beach, CA 92660, Attn: Equity Capital Markets, by telephone at (800) 678-9147 or by e-mail at rothecm@roth.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: #FEFEFE">This press release
does not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state
or other jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities
laws of any such state or other jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: #FEFEFE"><B>About AudioEye</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">AudioEye exists to ensure the digital future we
build is inclusive. By combining the latest AI automation technology with guidance from certified experts and direct input from the disability
community, AudioEye helps ensure businesses of all sizes &mdash; including over 126,000 customers like Samsung, Calvin Klein, and Samsonite
 &mdash; are accessible and usable. Holding 23 US patents, AudioEye helps companies solve every aspect of digital accessibility with flexible
approaches that best meet their needs. The comprehensive solution includes 24/7 accessibility monitoring, automated accessibility fixes,
expert testing, developer tools, and industry-leading legal protection.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Statements contained in this press release regarding
matters that are not historical facts are &ldquo;forward-looking statements&rdquo; within the meaning of the Private Securities Litigation
Reform Act of 1995, as amended. Words such as &ldquo;anticipates,&rdquo; &ldquo;believes,&rdquo; &ldquo;expects,&rdquo; &ldquo;intends,&rdquo;
 &ldquo;plans,&rdquo; &ldquo;potential,&rdquo; &ldquo;projects,&rdquo; &ldquo;would,&rdquo; and &ldquo;future,&rdquo; or similar expressions,
are intended to identify forward-looking statements. These forward-looking statements reflect AudioEye&rsquo;s current beliefs and expectations
and involve risks and uncertainties that could cause actual results to differ significantly from those expressed or implied by such forward-looking
statements. Forward-looking statements contained in this press release include, but are not limited to statements relating to the offering
and expected closing date. Each of these forward-looking statements involves substantial risks and uncertainties that could cause actual
results to differ significantly from those expressed or implied by such forward-looking statements, including, without limitation, risks
and uncertainties related to: the uncertain market acceptance of our existing and future products; our need for, and the availability
of, additional capital in the future to fund our operations and the development of new products; the success, timing and financial consequences
of new strategic relationships or licensing agreements we may enter into; rapid changes in Internet-based applications that may affect
the utility and commercial viability of our products; the timing and magnitude of expenditures we may incur in connection with our ongoing
product development activities; judicial applications of accessibility laws to the internet; the level of competition from our existing
competitors and from new competitors in our marketplace; and the regulatory environment for our products and services. We undertake no
obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except
as required by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Investor Contact</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; color: #141316; background-color: white">Tom
Colton<BR>
Gateway Group,&nbsp;Inc.<BR>
</FONT><FONT STYLE="background-color: white"><U>AEYE@gateway-grp.com</U><FONT STYLE="color: #141316"><BR>
949-574-3860</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>aeye-20241204.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWa6E2bOdzZR+SYkxtmBxbQlabyYsHUeSvySkg2ymEXcG -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:aeye="http://audioeyeinc.com/20241204" elementFormDefault="qualified" targetNamespace="http://audioeyeinc.com/20241204">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://audioeyeinc.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="aeye-20241204_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="aeye-20241204_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>aeye-20241204_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>aeye-20241204_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://audioeyeinc.com/role/Cover" xlink:href="aeye-20241204.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://audioeyeinc.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45089124499344">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Dec. 04, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec.  04,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38640<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">AUDIOEYE, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001362190<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">20-2939845<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">5210 E. Williams Circle<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Tucson<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">AZ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">85711<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">866<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">331-5324<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.00001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">AEYE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MW&,EC'%BM/XU@LD/['X 4$L#!!0    ( .E!A5FJQ"(6,P$  "("   /
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M              "  <T!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%
M  @ Z4&%6=**F)-?!   '!$  !@              ("!#@@  'AL+W=O<FMS
M:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( .E!A5F?H!OPL0(  .(,   -
M              "  :,,  !X;"]S='EL97,N>&UL4$L! A0#%     @ Z4&%
M69>*NQS     $P(   L              ( !?P\  %]R96QS+RYR96QS4$L!
M A0#%     @ Z4&%6:K$(A8S 0  (@(   \              ( !:!   'AL
M+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( .E!A5DD'INBK0   /@!   :
M          "  <@1  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4
M Q0    ( .E!A5EED'F2&0$  ,\#   3              "  :T2  !;0V]N
E=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  /<3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm2430240d1_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://audioeyeinc.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>aeye-20241204.xsd</File>
    <File>aeye-20241204_lab.xml</File>
    <File>aeye-20241204_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="tm2430240d1_8k.htm">tm2430240d1_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tm2430240d1_8k.htm": {
   "nsprefix": "aeye",
   "nsuri": "http://audioeyeinc.com/20241204",
   "dts": {
    "schema": {
     "local": [
      "aeye-20241204.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "aeye-20241204_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "aeye-20241204_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "tm2430240d1_8k.htm"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 23
   },
   "report": {
    "R1": {
     "role": "http://audioeyeinc.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2024-12-04",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2430240d1_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-12-04",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2430240d1_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://audioeyeinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://audioeyeinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://audioeyeinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://audioeyeinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://audioeyeinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CountryRegion",
     "presentation": [
      "http://audioeyeinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://audioeyeinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://audioeyeinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://audioeyeinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://audioeyeinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://audioeyeinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://audioeyeinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://audioeyeinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://audioeyeinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://audioeyeinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://audioeyeinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://audioeyeinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://audioeyeinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://audioeyeinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://audioeyeinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://audioeyeinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://audioeyeinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://audioeyeinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://audioeyeinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://audioeyeinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://audioeyeinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://audioeyeinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://audioeyeinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://audioeyeinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://audioeyeinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://audioeyeinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://audioeyeinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://audioeyeinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://audioeyeinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://audioeyeinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://audioeyeinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://audioeyeinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://audioeyeinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://audioeyeinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://audioeyeinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://audioeyeinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://audioeyeinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://audioeyeinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://audioeyeinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://audioeyeinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Extension",
     "presentation": [
      "http://audioeyeinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://audioeyeinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://audioeyeinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://audioeyeinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://audioeyeinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://audioeyeinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://audioeyeinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12gTitle",
     "presentation": [
      "http://audioeyeinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://audioeyeinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://audioeyeinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://audioeyeinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://audioeyeinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://audioeyeinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001104659-24-125776-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-24-125776-xbrl.zip
M4$L#!!0    ( .E!A5E81B>[+ ,  .P+   1    865Y92TR,#(T,3(P-"YX
M<V2U5MMRVC 0?>],_T'U:\8V-DG:$$@FS:W,D*:%)DWRTA'V0C38DBO)8/KU
ME7SC8J! 6Y[DW7/.[GIW99KG21B@,7!!&&T9CE4S$%"/^80.6\9#S[SH7;;;
M!CH_>_L&J5_SG6FB&P*!WT!7S#/;=,!.T6<<0@/= @6.)>.GZ!$'L;:P&Q(
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MVA)7;$#F-!-F>1 L *9,!@H94CI4"+WTO+Y+P#+U$"/8'%/FE@"[R28%34U
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MDJM6VFD:J8NPHL2_^^XKH$!1$M J,PWSO)7NV<=<BN#]V&,5E"M*)NDSU?3
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M0![]7RI%CCDSC3+I,.^0G-,A*Y.),3DDS;K\Y2:;J]U\[OR1JY]4JQ?P'\Z
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MY'2_<V2>W/..W&H$WM$=ML>NL_4H$3L: J/,>0W?@>F#8AB/4*"G8&-5[Q[
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M+AS=O<:,:\SJHVC,7ZKQ:)E-V7M<(PN-LT</0/(@V1T<C=+Y[?'Z%H\L[CZ
M;_.,VQ;]P>MA]4:$HJ)K%2MQC!\<XI@P$*Z^389EJ&K<$I0S;US!C'[-O:(V
M31]ZSDX$"2=IR+@0=S01W5%;L!4N<N+5:C*%0PN61(  <WC!7BXD>.H4R6PN
M/9*DJ(/Y-))-X[_X%4.?%6N+0#;M.RH'>I9=Y54PRP>)KBLD6/&'8DI\/'WJ
M Y<DHBZB\DL>,\EUQ4NF@>-(^L%G32@B K84K$[+>5C3?".S.@*3*9@LR5MV
MA<S2JYW6,A4COS8 (.I''-4"\LN"259FG/0B;:)S /U4SWGO5?!?$!T,&(P4
M>O-S5+("2<AWU]UYVXYXHK\+L<,GU]IK=^ZD$[_UO@$0K%OKX'L[SZ'@]?:4
M[?UV_.:X6\4.8HQL3LG@$:NM*Q"VF6)+_&16C)*:_D>-/:*OP.$9#LFPO]OX
M^@SWY2NPE87/^ (CG"XD,\1;&\[S6FP1PY*2@;1871Z7DG=>V1Z6=?OF"\NZ
M?7.?=?O\+;KUQP35BG?H>D</N(>&T)I)PI4EB_TVECZ!BIT(,R3S9P71S'[8
MC>A-^ _2;V8?SU8J841K\NF8NM1IO5H%&O01N[P7'8Q=[].HMP0CYV,]ZH2:
M%C:Q10G_;-='W:BYXR>IN.A :*^ZJG\\8O,@^+VAP'*(>WY;C)BJ:#LZVP2!
M'+W11"FAR621=I<Z+S0X_21<%(!W+^"G[D^87NP)I0R)E##8Q$-/<;X9T)^6
M<,9R)X8!BM@@T!#8D'HDWBM..$H$WEL ^NDXS8T!B?K^2$0Q(SR-A%TB\R+M
MF"!D!; 1TF>8S-ZC:,C+RZ*N]*6P36TNP4>\0VLEN[O(LR5:/=0'>)$31QI\
MF'C]B2:[W9H_=DT7&@:Y=&)WI8;.BJQ"0AQ9AJIK<>#O\,'NO'7Q:03_OS]I
MGY&>D>V#9\/6=IPCJF=<VS.^!D]THY5K_FP32O9B PNEYUH":^8R6!JX;#4M
MZ!@7-<;DZT6&X^*JS_,:99G\L*0K(!\@_WJJ/U'\.CL*+G-OO+EV#66_CUH/
M85UFCDDAI>-P07K_ZT4RNX#OSHB5CR?-U:,$<,3Z$^6F;*OWV-0;Q=9_LGI>
M;1H*JBH>%VLCLJ9E](4E%)+ ^#_T6^Z^N1IF+G_NK&(:(#=Z#+>P QO,5:)6
M(GF"&&,"'EC@0(I):.3EDBPJGH"JSLZI%7BSKJC/$I48<_LLG%PYU[Y^D2%3
MGOLJ1P^N84?.UM9Q.GV."\^:@_X!0YWS$O*_DV4NDLSS%3:>QK#!?.R,8">:
MMVE$SZ%:=U\FC82;A@29E.S4HD'C(&)8EZ (*9.*XS^P5?5F>:[L9%PIJ)!M
M-@H4@OLB$/$_PZ'3/7MJU"C)6P_1QV[8/"8W$4I*B&F@7%(^L<HN]JJ?0.V_
MWC:%V9$$?MHEZF+AP+QI7>DPY!*[&@">C=L6OV@P*/:'G2XB+L5N&PQ#IV@<
M9R[)KA2;.O/YYFC6'!?Y$&_Z7I]=4Y_5GU2?45+&ZC,02@UU.D(Z=5,<VF%5
MY .K]TS@1N)2T.%<UX@>&J1''(]4]45RH81&\WTN#[IR";7WY+)\!U>+H1Q[
M$22Z"#IM<^&L2?>'HNE.G+F_O^(7^.H""D .A*^[?EE8D.0+%Y'GPF74^YSL
MV$AFYA@Q5]7<\Z6+L-'AC4<\OOL;&[^QS=VZL7M(R3#PC>PR!5+X4%29.'O8
M9>HT$2,UB$^)/ ZNB3Y/5&Q#_M7 4]BI;TP"@8^AZV<6J2KI3BT-G2PD3N.8
ML.N8B2.A=IGN>B_(TQ7-1W\BR<"$[3H8E^&F5UYB\-,5\KGY$$=H[WN$7T22
M)9_%H59\@NSDLGC"N1KZS=ZS!QJ6A.'[H!4R3\75PF2:F@!!&CK.SM(1-QF_
M(I3.1BXCVJJ^S&T5EH"]8&K<K+Q7BD507J*."8? CR>J;Q5A2-A?$E:<))BA
MY%[G<&BHN69R1KD:>X2X6&FFB.2+?*F 3?(7#EDV.""8U\^7_BCR$PBND'++
M5]_2T;3]2,0GH;GVB1GB>]1U^NZ^S#PL)_#M%Y83^/8^)_#Y*^;V4U?=#^KG
ME'U[I28C/Y)" Z1*,2I"'C3]P_;L:2@\@'Y[_<[^N_,9E.4%E@?9SR5E1LO%
M/S08$&A)I6*N@;\WJ]9;'I!W^A/?3 AU'852-E9(RPRR?EME9[.3OQVP]U"W
MVBACQTT->LX3.S%MTL&-9&X%"<-9W&'C?)!_^J6=_BN=_FN::P]AN1.!PKF)
M01M>+?@)TFO $>@4#9$IQ1D)'M^N@=&CB4P 8RW:O81#+5,B"LJF,-*JE,89
M11.X,_Q-BK?I5_F;B?F:UI%=5<GDH=@G3-X@'4MMC5H(^G>E9A@+V>U='1)M
M<$GZ/XKLQ&/BMR05=LIP)K=4;9<ENLV]3)F/4SGV%QRF!P(YMIB=1T ;#M&2
M+;#2/:=^.>P'NM8VOHS'E@#*K3DLD>'IQG8@+?>AF5 &1N<S'LF$T,RREIJG
M;6/4N2O.T>EJ5\"L9$DFU4I5T)AZUQH&\!IV.GJA?YHX=^UU*Y1[_C8M B>K
MER/X7"J#DA@;NG404S0KYXMDCGR\" 4Q19M=54D0U# R<"ZQO5O$P0PW2@F@
M2. &NNRBTJ4XYD0D;9 VVJ@1*,@$W]L@FTNS;> .8= Y!\E">NPBJ^=7&29^
MFVK1\K_@/H(HHNCT53[%AI:-,$VAON&RH(WX7Q*7Y[ [?'>5%42;P,*:*W+H
MAF=WWV[_-";5YF[%.MC?PFO%3<_IGTS6#G>J.B^I0Z>7RVA98#6L(.RT.(2<
M\675J+E3%\T[:>[.!!YPH%98?>&Z:JSKS5SSP3-8>U@])I2Q,0TJU+V.ZYB7
MYV#&V\8GV&:<^H!I*Q:,3J:FX2<=7$8>-CQ_0;S!E81G':KO/)TNW7H.5AC8
M:M%ZQE=2_LM<BBE*.#R%$O&SS.T.@FM$Y\S^0VOM_L+V!><#71,?-2/=I\B,
MT-^Z33;<*]WH,($V:5@NOJ1X@RS!*DH*=A(,%+O)J3':W,<X!^[]Y<>\]P=7
MFEF>*7<)JMI<C[TDL1R_VF.2H/GCWS2$N(\\O6B490=#C 9:7FXME704TMYY
MU*12R%E6D@LE3A[= S>DU*\#]S22A;#I>L$,*5 [ $=)4M13V3(]+O>0DV#C
M8E.717-!B7\B&)=QX 5&Y%3:^4XM!7 +CNY5=218S-_%>][]-@G4JJZK*TF#
MKV KMBP2$.>6"U&P^PL_RJ;JT>\D.B@.43;F;<.%[T$APF$5&V0:2A\K)_BC
M+_"<X\%;V$82% .:@1Q>SKE^L:#N7Y%G49^O/$\#$EU?;%%K5[!._!Q_>#^3
MV/M_G3X\24].3BPE11 [-_'=)EM*I22U2UVVW&$P;\)S62,I4TT=9WS<NLZ+
MU10Y*NAA^/D^J0461^47V7(12PJ8++HT#M/5FX(N6A0<T]"C;JOR WI>2>['
M"O?O:Z@.4@E7'[_OWV$Q=X%2R.<[Y0TQ;L,W63W-P$AX\.O[94ZUF/B7AR<G
M#YG=<,7L8D(M0X::$JUV6QQHR2>]>6 $PT1[%@K3+P_T@)C#1](O"^FMGSI!
M*'G(Y6)N!Y [**$-FYYCYF@V*(.*7"A=6%[GUNG-&K4!<: &!QWT3Z#Q:Q_X
M2(()CF'&6L@5@FD?<Y0SVD2\AWDR/#W=UZ%74,^9MB0P&CG'+]2#+@T^$-$A
M5[W"+VS#5!@S21;*Q4<]4F4%':6%A0&Q^TO4B<0 @?8"#80B=.4RVF;^)LLB
M+G' @F,6(Q@B264_(+Q81(WCC!1GZLN'LM;N/1T=0E1EW,G>)1DSP2S"0SE,
M$BMKG!<+Z5D3J6F*)[M!/\*;P23)Y[;*S)U72</.\CG%7R8422;V&H+<!FQ[
MK_WM/'V4/3A]XCCW\"FG3^;\JR-GF^S-V<Z5MH51X?'Q"69PK@&BG)P<\;U\
M>=P@^T<W%2K6<BVQ\8)YN1J!<A*:)=YBA79'#T:J$1/F5ER!UB&'FN46/MJ&
M?Y5+1(D9 QK,4);YPLY0&.)$>=N=T/=D^80^VK(5*#8N;S\&R93E-<Z!?<"I
MB.,/HD26# U5H*#2#I.WZG?BYEUND@F?%(YH^_S#"YXG7:'GGHKI*+PFXF_P
MJN]KI[1G("V70((QU5@B6+\3:':KNS%%[_J/[ !&\<CXXR!G[J9KU]TO C6B
M.4X,$5[G;UJ:[R$-V-"#9M?HD71Z3FFD<!.#@!&N#YZYB6640KFH!%CR)%VX
M\0@YHX9(4L.*3R[IN<S[0!2?C3%AV&7QCCH%5OW/I]'9P/8,3>> \=U]P_<P
M[,+IR1<&7C@]N4<O?/[^U?L/@EXXR.GZU82:NDUS(LQM5I!$V##G/G1,O^V4
MN2\D%++ I:PMJ\2TKM[YWR"RC<'NY];TG5G^E&@+$"G1Y_9X!$4#H;B#E(:"
M&JN5<P+(L#&.!',4!EV$IO=1@H%3O/UTIS@('3 _#SOFPM4#A]O16CK$!D7@
M!,0=V?M^ RF,=]K4B* C.L^VG%Q, R1T&6+C,JFFL:17>58:/?W2?T=G)&&*
MTV\?G]@P16@--A><4V6\?(%M)EQ&A%Q^V,02DZU5+,]#+<D.&;@!=-:VW8RW
M*_L3($/I!C-(AB:0-?Q^7Z]BG:@VQE-#DV5PPP>>[>!VW<N-J-SXSR>6&]?K
MP>Y+U3#(M$2V9?5D.GV\79P@PI"ZXPV4#-NMASWQ#.=VT/_B(,#>SAZ=5N-Z
M_WP_1_)#\*2CASL>#7?X>3B9^BY@\--YV :LTSFFPYY$K (4&'+,D3YZ(ET^
M)9M>L2SSN9BB,>X1(W&<*\I .<&O*;U:<'--AQ,WYP&?.$)_8,@.M/[&U=+$
M^GD5=BMI/&9LY&/:P47[*&N'"UAC3'NU%Z91DF&%UW!TEXS!I;XZA[/JP!6"
M$V I O2(UPE(1($%F07'68?L&(6:A;U /0'I)*!(=?74<8S^W@W6T]H,'%9Y
M"Y\J7B71!12D'D0SR#JBM]/DTO9UTVJ<@G $G@\K5J_)X!%30S T ]]T+EA6
MX?5#?04BMI"^L_ #+&1=E<6,#9 %'48FT,8!/\^)_1GKY-YB_B],'4MJS 1&
MJ4:&P_C<(9PS8OV.?,HS"-,U.3]:HYPEXL[7NZY<APWA2.I@0[.=TZ+]%;C7
MEG%MF65'-]6%T02;DHX[0",>=)\O459?[01J&VEQUA=^97M/*>"@D@["W"&9
MR<O3H%7!:BH])K'\OT HTAIOZB1$+P1L_*)X'1!=%>*1!S0H=@BSZ@]P1A07
M<YU_A_N^PY!\T2LGQLSAY<.N:"686$O\;S/N4'RD#B63L"ZD,T#T05H>1SEU
MKKQF<]0MHF,BE0Z6=_XF'!B<._W2@G.G]\&YSU_@3J<W]D]V.Q\_9D2?+[Z#
M[:D6[0W0#>/'T0BVGPYU?R/O@T2S YA'A9\D>!$FE'.KM82!L"RPR(CJ]R18
M9P5Y/PPKU_SN 'NL2R;/\VEKJXU,+QI,Z3OYCS9_F9B6.N:#1]+\DXA*B2$L
MVK/'O5SF)V6]U!6D0)HK4 @FCM"L* 3!_59(#L^R&B.(91B/(*/S2F,5$OO,
MFFX)L/^[GY1MZ%+R6F?O&$W+,'E9])RP7,5L0^W&]1LQ4(L;E7]=F"-.P],E
MR;C?&>4??3(WXN,_9)<9:#T.X9*E[W$OG5X]:D^Z%GY]!NWJG.G3G#\@Q 6=
M1J["74>N3,JTX 7YH,L"1HG3X/Z'HFIY<V%,BY;*G_OK2<@<.$>S8DUKL&E\
M(AB'F_JV&Q[S0FB1;,M?%E1X][ 3')$99WQ#)0]_=F#R.GIW!KJW<"=F\GTI
MC,X79IIO*TG>:41=!LC =;E6P;5()D.GJP5C1MP8-S=I=J3CH[Y4T>N-8\#7
M'6D@$T&S6 @V'H6%8#%LDKAL ;J2T@*9$L\'_5;93<66JG(&H@X>=?5E#&I5
MGV>EH&&HKDH/36C_3;/R7;U9M]J8P7[-&7+,RE<7S;SP3HN9;S(\W:#CKT<W
M1P4W%_UL6IPSHQFQEDCNZJ;4GUZ6N.CY/$:CT,,1I\(?[_U\;_W'JP(HP:+M
M+P^L)@B9'6,P'SOHX^2G2L@TUYL:1643JQ5T99C^FQJ1Q6AYDTS>.ZC.-KAY
M"^*_1 PQ-K$AE#".60_X%6?Q&0Q+5_>_GC 8=F+0L%PW*Y>E<1?A&JW8D(5I
MJT.$K3W?9#6*'V8OG%>"BA5 D&>VUM9QX$>?2^"N<_$Z)X"^RNV66T-+R6%'
M]"JXI+.Y\"1/NQN[<1,YIRNFV9*B&^#5PPF>5)%&MKYKEI\E*B S3QQIF9]7
M;2$+J;R<O&%SCC"P2\0EN7)SU>,*$C/[EU]8N/YC=).VP/5E=GARJ"#$@<5#
MF#0?#&R8D5LJBEX?==&3!)<:X,ZX^R[<I[&M9[,_&OL_K+QDX5D\$]-CZ\#R
MR%OI.Y*&0=(H2H@ ^Q-/;N>[<DDS>9 D05?L8>I4C#FL<@=*5LHM_C4' Q<(
MV[W NHDV>P]3 '.A).)&7V3/O1(S97SW':9[:K'#K^NZ,UNNOH;=!6*^0X8:
M'D:?O9;,N:8QEBB32B8."NVHA7#%2;:G*.*N2N8ZY""[ATYNR(B1<'M_FF@Y
MF7EV#-L+J4W*&D0^JR-05>\:$U4R1P-V[-\;(D#K,?:$S;=I#>A3 J-D5DMN
MM*K!5]?Z6M<W/@N:MIW#>KW<:JL;7#&PMS8E+3^_MN#^?VXPXNM1+;IT3Y*5
M$U<"OD;FHN<5[AM'/L_C2[1Z1HI\SY@0: B2AJBD1_M">1.X@A#'="]!XQ)T
M/O] T8D#B<^9)'Q/O53,-B4A&/3)E5HQ"CEC@LB4!H6CB#P-+ZD3G/&>I"G7
MAI.C >J<3]FF!$-_L1$8I8298;W/BP41!V+,$!'^ AI24\U]S54T<5\;DC@J
M:_%.@K"%<S!#?ENP3XG[%_&R6AT@ W:]8=US56;$'S<>>7')5PT98O$3IF"Q
M5OM[]W@HR,"?GV6POO!)(?/0H'7.ZQ64,R#?@(@)!:;#IPBDJ@D C=G3Y/92
MSD^JVGV2L,W=LT!2UY6*]2JM"<R>(4_ D2JB/L4Z+&[*?.A:&R%\&?.>/%23
MFW'6*N;E6/\D*_H,' UP()-7VN7$ %V^_OH>^[%??.7YAS4 W\;*"TRATZ)@
MA/>NXN,(CPFJ.8I"=.L64XGZ=-Y@FD. T6, %M)0M?>%+#2W>M"$D"&0@5,@
MBVK"2J$]L"Y*EV+MM+AUP670K[[429OI"(6-+$,)VY^<E27RI$C7]\^M9/+
MY-3#+RTY]? ^.?7YR\_%XN/)3P?X=BGY+N;;_R%L^8PJE@S_(#OU#*P&[A#=
M<M5]L>!/,LS<@ I^E:)N^XVT(P,)KY/;3%F ' C@=ZF6ZN>U]%5SWF0,5>X^
MR,U",$$?HOE,Z%#JLI#"A6)3VA)\0[1%^)U7[C?\\VN+3GNC IF'^!+9M>OD
M)VP%\R^DQX9!^.^/1X+-@G&_F5WD\PVLU<N7+Q..RZ4FPZ93;#R2PU>?BH)1
MO4*#"H&$KSV0\.X+_$]S$\_//Y C%KN"J58@HZ[W9@DXT)B7B!K-\$V;'4:H
MCQ)+]#TE<LYZJ$S,0FZX"T$0\Z)@,Y<42_:$C/FR6)M>01R#5=([1'LK6UK'
M5T27AXF N5&\XF>)+%(OG^%RTRMMS*$*VTA/"RHR33'1 )93PW5VJ<2@R$M9
MH?/&(R0Z"U#1,[YD^IW&M:+JO U]0>,/<1Y<VD_--2TG#IA0T.U[IT+Y\,OR
M>GXSXYI\I^<>98V7/PXL2K0?F,^COA!-O"=$UACR%%]@3(^P"9G[.Q^_\Q<7
M'^C.O\@PGQO0E9QC9J5?_3T(9XN0G5S!?NMCO$?2SUA0N(]:DW0B+SN>'2IC
MH>7 >JQZAH>+;W[64@JE1;X^SPM/*!5FF^]A5!Q\UN%D*&E*3E8P")>]Q^Q5
M060T;JZ\1HZXP1@6R^P*:5R3Z$KO0 KVY^_@TE,P^"EU%@5SD["&RPXB5U[C
M8J:.TE)1S5K'[,J]451LN2L4QQLH_M)Y8AI,IG&&6*>KD?_6K.)$F@A;>@@A
ML(/'X(ZF@J;GK)D/VY$+B\'\$GS8F4OX&;/*LAJ<9_4\TOB\EPSAZ'D1UC2C
MRFFD,1990??VR(!L@KOX$7G<0)RXE#PE'9A55X^P.PI.Z:,#.;OPAP@58UVM
M"M9:E?;-YB8F1O]V)5$ODNC^$K2:;O/915DMJW/.O-V$>=0"DT4090J%,336
M3!')[0(]55NS0:&#OQV/+CDQ[HB#3#]J?JC2RK"TQR6R+%E%BPEW1WA*?,UN
M<O$.:"]AXWBB]%)PGS)EE!"RF&T?.;>#A<7U)>7Z%VJD%51C]* ]W.64:<0$
MSVCRL#Y[1A2/T<QJ&L9G#SE(8A]'9O\T#A8<H@*I<\/MM[^O-F.':FVDV;@L
MK&FTICW4=E9L<?MZZOE)!SWH^AED3"O7>\UV4R*\OO!$D/90HAJE!$0M;+$F
MW<Y!H#PNLYFP(%N#/;*FZI((J$_:%KI:GM@W*,VP*96^B&%YJ5 %IPELHN<4
M4D2(;5]DR:NOG]$?3-4_[>(:=Q\/>ACUV%DQ&XNK#.([C*@J-(-H.)8N.EOD
MB)CA[*[GYF)T)I%&$ZF+#M*21H?236\J;O8Y[[M4-&$+028[IN4"JPBL&CBX
MTOC4["A1<<=N2I],:I> $-)]NQQH$6W6C"> '<7 -]$.46F^D5UDN374!X%N
M%6PCR-*:&M+"H'&=>&TDV7*O^>.:__??/[+F=VI_/WV?5-XS'K>EF<TWM:K4
M-?H&V"R4L94- 7\'J_&,Q"6U*<**$1WN:),P[HC6@'4Y:\R3V,1]L4&R4K#J
M?Z,DRM^%<HUDUBLOVGQ4S/5Y^_OS5Z]=<]')B]_&HX<GIU_][:NOOST:T,VO
M9-1#+2X/T\@%N2&S/-6FCFROTQ>R=PCX,>1L<,?6 =N0B?%H)7VD=!-,\4")
M&#XGJS>Z>^&E#&T,!2<<R,^T1271[[FC4M\0E0VE;+E%; B(JE?**4L;,L$G
MZF+*^(*%C*PD<; ADR$E S>4Y/8M&0A@[0^7/E3MB;B%9ZTX:^'5N9@.&6Y\
M8S-[8.QL$[O_76$;&X12,+IQTQ)[R+J?1LQ<AM^5#Q2F[[2[$ZG!1E(-F_ ?
M,'B.#Y0OH1!]9<RR2IL!7V< 7J2G5/QN,Y]V>53=A^2VFG(U)L#M(/:.QR-W
MKNR)ZR"175PM*1%QGVF#/#=E;,:#Y[Q&!&TVG]=DW+3@1J\O,%Q;;I"\%P]3
M5BS]!^"/;07>^/H"5J6I9H'5J]]!#+NU!<C+UP-*-J,@_OD+3X,XX#;PS!DU
MP6M(W=$75&0D*Z \SFBBLQ'"_'SF";HN/F[R$Z,3J8X[*(MG3@"'C@BN:>>%
M)$_TT9;.$0X'2MO>G7$1TW61RWTVLV0(X7)977'%B<S%],.DTQ1N)?=PDKIX
M9%DCU<Q!8.T8&LHU]DN]R*+%EE=YC65 0Z!L].],VF=/D&_XW>3OR6:O"Y8H
MR!G@3B#V(V*>[I!^TL-(Y<YZO(O<4B==/(%>4:J$(4,<RR](73+2$&YAP6HG
M -A0M%NERL^J>4-EYCB:4D_01.HDKVF;2I5> >.%RS':BZN^7_!B[M8,P]1)
MP?7YN')CJ'2"E5_8YM*B?0_@'7?L#I%&0IRSV0CO>M6*I^#IM_AA01%(SYJ@
MR\N<Y9%G^<WN [IZC^ID3D)%Y\\$0F(\,8*4L E#Q#K;"CE\RC3KU5)Z&Y&F
MY><S>X_XL+A$JWQ>N#R41@7J6LF3^8):8I.,NF&H^XP<'__>"!.[-$[O?MI,
MYBDCRLQ\NO3_Y.MK8_;4I8FT4U%5>QKKB*]/7N\ASK[40ZVX )%>[%Q[XL]W
M!\$SHIMYW'UWZD DSZ,O#<GSZ![)\_E[[>_>?5@DSTX\MS@]H6HZ -@="'C7
M@<1T)@DAR<%W2:[UW\JM+WP(CQ[!C3:$.4/I<KGKM%@U-9I>4IJR\]O?A2 D
M<7 <J* !^T-**.:KHE28)CV&NM"Y#.QOQV^.D1L')+UFO-[6U/C->SN_TCK@
MGQ0R?,9EZ,]XR!QND)*>7S+AG'RC5OXSS*<5RUA0(DW^ 2+\G]GOH*?\^W0
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M53,%50Z7)83<9"95!IS$,VR%G9O)?!.V#)K($B7))+R__NWM;-*1,3L$YU,
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M;0NUB%(-V3'#PFK>&#$,PYR:(RG;5X4M#0.$)N!K>-&*1_U5IZ!UM)AB1*_
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MQ\;NX6%7G(> .'RSU.TS1;9A>X&5!?13J&IJ#4OQ^&@P>"*.!_N]_;V#(Y(
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MK@',N8=708WK"B'BC=X9#-B0PN!8G"F93"-Q?BH.MG9W![4UHX\5T>!:_B_
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M              "  =_8  !T;3(T,S R-#!D,5]E>#DY+3(N:'1M4$L%!@
0   '  < T $  ,KD      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>tm2430240d1_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="aeye-20241204.xsd" xlink:type="simple"/>
    <context id="AsOf2024-12-04">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001362190</identifier>
        </entity>
        <period>
            <startDate>2024-12-04</startDate>
            <endDate>2024-12-04</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2024-12-04" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2024-12-04" id="Fact000004">0001362190</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2024-12-04" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2024-12-04" id="Fact000010">2024-12-04</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2024-12-04" id="Fact000011">AUDIOEYE, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2024-12-04" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2024-12-04" id="Fact000013">001-38640</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2024-12-04" id="Fact000014">20-2939845</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2024-12-04" id="Fact000015">5210 E. Williams Circle</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2024-12-04" id="Fact000016">Suite 750</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2024-12-04" id="Fact000017">Tucson</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2024-12-04" id="Fact000018">AZ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2024-12-04" id="Fact000019">85711</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2024-12-04" id="Fact000020">866</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2024-12-04" id="Fact000021">331-5324</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2024-12-04" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2024-12-04" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2024-12-04" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2024-12-04" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2024-12-04" id="Fact000026">Common Stock, par value $0.00001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2024-12-04" id="Fact000027">AEYE</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2024-12-04" id="Fact000028">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2024-12-04" id="Fact000029">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
